| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atherosclerosis | 175 | 2024 | 3418 | 14.880 |
Why?
|
| Arteriosclerosis | 140 | 2008 | 1055 | 11.500 |
Why?
|
| Plaque, Atherosclerotic | 82 | 2024 | 1549 | 8.770 |
Why?
|
| Inflammation | 152 | 2024 | 10869 | 7.040 |
Why?
|
| Muscle, Smooth, Vascular | 115 | 2019 | 1493 | 5.210 |
Why?
|
| Macrophages | 140 | 2023 | 5785 | 4.930 |
Why?
|
| Endothelium, Vascular | 101 | 2024 | 4424 | 4.480 |
Why?
|
| Cardiovascular Diseases | 95 | 2024 | 15645 | 4.420 |
Why?
|
| Coronary Artery Disease | 98 | 2024 | 6573 | 3.900 |
Why?
|
| Acute Coronary Syndrome | 31 | 2023 | 2193 | 3.730 |
Why?
|
| Anti-Inflammatory Agents | 33 | 2024 | 1804 | 3.720 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 65 | 2024 | 3249 | 3.540 |
Why?
|
| Inflammation Mediators | 39 | 2024 | 1889 | 3.360 |
Why?
|
| Thrombosis | 43 | 2024 | 2954 | 3.220 |
Why?
|
| Interleukin-1beta | 25 | 2023 | 1027 | 3.080 |
Why?
|
| Monocytes | 74 | 2023 | 2598 | 3.030 |
Why?
|
| Arteries | 30 | 2021 | 1123 | 3.010 |
Why?
|
| Myocardial Infarction | 92 | 2024 | 11513 | 2.890 |
Why?
|
| Interleukin-1 | 42 | 2021 | 1252 | 2.530 |
Why?
|
| Aortic Aneurysm, Abdominal | 31 | 2023 | 1250 | 2.460 |
Why?
|
| Interleukin-6 | 38 | 2024 | 3227 | 2.170 |
Why?
|
| Dyslipidemias | 9 | 2024 | 872 | 2.160 |
Why?
|
| Cytokines | 79 | 2023 | 7446 | 2.110 |
Why?
|
| Animals | 426 | 2024 | 168965 | 2.080 |
Why?
|
| Hematopoiesis | 16 | 2023 | 2056 | 2.060 |
Why?
|
| Fluorobenzenes | 20 | 2014 | 179 | 2.040 |
Why?
|
| CD40 Ligand | 33 | 2018 | 528 | 1.910 |
Why?
|
| Cholesterol | 29 | 2024 | 2905 | 1.910 |
Why?
|
| Metalloendopeptidases | 22 | 2006 | 386 | 1.890 |
Why?
|
| Dioxygenases | 7 | 2024 | 353 | 1.850 |
Why?
|
| Cathepsins | 22 | 2018 | 243 | 1.820 |
Why?
|
| Hypolipidemic Agents | 19 | 2024 | 609 | 1.800 |
Why?
|
| C-Reactive Protein | 44 | 2023 | 3851 | 1.720 |
Why?
|
| Coronary Vessels | 48 | 2024 | 3114 | 1.710 |
Why?
|
| Leukocytes | 25 | 2021 | 2034 | 1.680 |
Why?
|
| Heart Transplantation | 39 | 2023 | 3305 | 1.660 |
Why?
|
| Humans | 661 | 2024 | 767040 | 1.650 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 38 | 2018 | 692 | 1.630 |
Why?
|
| Heptanoic Acids | 19 | 2014 | 344 | 1.610 |
Why?
|
| Lipoproteins, LDL | 23 | 2022 | 640 | 1.600 |
Why?
|
| Cholesterol, LDL | 39 | 2024 | 2392 | 1.570 |
Why?
|
| Immunity, Innate | 21 | 2023 | 3076 | 1.560 |
Why?
|
| Anticholesteremic Agents | 18 | 2020 | 969 | 1.560 |
Why?
|
| Thromboplastin | 11 | 2020 | 289 | 1.480 |
Why?
|
| Inflammasomes | 7 | 2024 | 540 | 1.470 |
Why?
|
| Myocardial Ischemia | 9 | 2024 | 2131 | 1.450 |
Why?
|
| Vascular Diseases | 9 | 2023 | 1161 | 1.440 |
Why?
|
| Interleukin-1alpha | 3 | 2020 | 88 | 1.410 |
Why?
|
| Mice | 222 | 2024 | 81912 | 1.390 |
Why?
|
| Collagen | 31 | 2021 | 2636 | 1.380 |
Why?
|
| Hyperlipidemias | 15 | 2022 | 771 | 1.380 |
Why?
|
| Interleukin-18 | 9 | 2022 | 251 | 1.380 |
Why?
|
| Tunica Intima | 27 | 2018 | 455 | 1.370 |
Why?
|
| Collagenases | 21 | 2013 | 221 | 1.330 |
Why?
|
| PPAR alpha | 6 | 2022 | 177 | 1.330 |
Why?
|
| Cardiology | 9 | 2024 | 1701 | 1.290 |
Why?
|
| Myocardium | 34 | 2021 | 4765 | 1.260 |
Why?
|
| Immune System | 5 | 2021 | 799 | 1.260 |
Why?
|
| Coronary Thrombosis | 11 | 2016 | 440 | 1.250 |
Why?
|
| Receptors, Prostaglandin E, EP4 Subtype | 8 | 2015 | 44 | 1.250 |
Why?
|
| Hematopoietic Stem Cells | 16 | 2024 | 3408 | 1.240 |
Why?
|
| Coronary Disease | 34 | 2017 | 5914 | 1.240 |
Why?
|
| Cells, Cultured | 121 | 2024 | 18989 | 1.230 |
Why?
|
| Benzoxazoles | 5 | 2024 | 92 | 1.230 |
Why?
|
| Apolipoproteins E | 42 | 2020 | 1459 | 1.210 |
Why?
|
| Sulfonamides | 21 | 2014 | 1982 | 1.210 |
Why?
|
| Pyrroles | 19 | 2014 | 1122 | 1.190 |
Why?
|
| Mice, Inbred C57BL | 120 | 2024 | 22361 | 1.190 |
Why?
|
| Lipids | 31 | 2023 | 3322 | 1.150 |
Why?
|
| Mice, Knockout | 93 | 2024 | 14476 | 1.140 |
Why?
|
| Signal Transduction | 67 | 2021 | 23621 | 1.140 |
Why?
|
| Myocytes, Smooth Muscle | 17 | 2019 | 701 | 1.140 |
Why?
|
| Bone Marrow Cells | 13 | 2022 | 2412 | 1.140 |
Why?
|
| Carotid Arteries | 23 | 2023 | 934 | 1.120 |
Why?
|
| Neutrophils | 21 | 2023 | 3779 | 1.120 |
Why?
|
| Rabbits | 51 | 2024 | 4751 | 1.090 |
Why?
|
| Toll-Like Receptor 2 | 4 | 2017 | 348 | 1.080 |
Why?
|
| Butyrates | 5 | 2024 | 164 | 1.070 |
Why?
|
| Colchicine | 3 | 2024 | 256 | 1.070 |
Why?
|
| Interferon-gamma | 32 | 2017 | 3154 | 1.060 |
Why?
|
| Vasculitis | 14 | 2019 | 526 | 1.050 |
Why?
|
| Adiponectin | 8 | 2012 | 1115 | 1.040 |
Why?
|
| Aortic Diseases | 10 | 2023 | 741 | 1.040 |
Why?
|
| Endothelial Cells | 24 | 2024 | 3582 | 1.040 |
Why?
|
| Risk Factors | 92 | 2024 | 74886 | 1.040 |
Why?
|
| Extracellular Matrix | 24 | 2016 | 1733 | 1.040 |
Why?
|
| Aorta | 41 | 2020 | 2045 | 1.030 |
Why?
|
| Cell Adhesion Molecules | 23 | 2016 | 1612 | 1.030 |
Why?
|
| Pyrimidines | 25 | 2016 | 3044 | 1.030 |
Why?
|
| Matrix Metalloproteinases | 14 | 2013 | 391 | 1.020 |
Why?
|
| Apolipoprotein A-I | 6 | 2024 | 305 | 1.020 |
Why?
|
| Lipid Metabolism | 16 | 2021 | 1895 | 1.010 |
Why?
|
| Fatty Acids, Omega-3 | 13 | 2024 | 1399 | 1.000 |
Why?
|
| Tumor Necrosis Factor-alpha | 43 | 2024 | 4349 | 0.990 |
Why?
|
| Graft Rejection | 24 | 2013 | 4498 | 0.970 |
Why?
|
| Adaptive Immunity | 11 | 2021 | 733 | 0.960 |
Why?
|
| Matrix Metalloproteinase 13 | 5 | 2014 | 101 | 0.960 |
Why?
|
| Janus Kinase 2 | 3 | 2024 | 561 | 0.940 |
Why?
|
| Chemotaxis, Leukocyte | 11 | 2014 | 661 | 0.940 |
Why?
|
| Carotid Artery Diseases | 16 | 2023 | 872 | 0.920 |
Why?
|
| Molecular Imaging | 8 | 2020 | 822 | 0.920 |
Why?
|
| Arteritis | 6 | 2019 | 160 | 0.920 |
Why?
|
| Elastin | 12 | 2011 | 299 | 0.910 |
Why?
|
| Aortic Aneurysm | 3 | 2018 | 649 | 0.890 |
Why?
|
| Receptors, LDL | 23 | 2022 | 492 | 0.890 |
Why?
|
| Th1 Cells | 6 | 2014 | 1040 | 0.860 |
Why?
|
| Aging | 14 | 2024 | 8729 | 0.860 |
Why?
|
| Angiotensin II | 12 | 2020 | 842 | 0.860 |
Why?
|
| Rupture, Spontaneous | 15 | 2023 | 365 | 0.850 |
Why?
|
| Diet, Atherogenic | 19 | 2009 | 92 | 0.850 |
Why?
|
| CD4-Positive T-Lymphocytes | 20 | 2019 | 4405 | 0.840 |
Why?
|
| Cardiovascular System | 6 | 2021 | 839 | 0.840 |
Why?
|
| Triglycerides | 11 | 2022 | 2444 | 0.820 |
Why?
|
| Cholesterol, Dietary | 17 | 2019 | 224 | 0.810 |
Why?
|
| Carotid Stenosis | 8 | 2023 | 858 | 0.800 |
Why?
|
| Blood Vessels | 10 | 2010 | 1110 | 0.800 |
Why?
|
| Nanoparticles | 17 | 2021 | 1966 | 0.790 |
Why?
|
| Eosinophils | 7 | 2024 | 951 | 0.790 |
Why?
|
| Multiple Organ Failure | 1 | 2024 | 389 | 0.790 |
Why?
|
| Disease Models, Animal | 57 | 2023 | 18330 | 0.790 |
Why?
|
| Cardiovascular Agents | 7 | 2019 | 849 | 0.780 |
Why?
|
| Fatty Acids | 4 | 2024 | 1806 | 0.770 |
Why?
|
| Eicosapentaenoic Acid | 9 | 2024 | 565 | 0.770 |
Why?
|
| Matrix Metalloproteinase 9 | 17 | 2021 | 633 | 0.760 |
Why?
|
| Receptors, Prostaglandin E | 3 | 2008 | 56 | 0.760 |
Why?
|
| Receptors, CXCR3 | 5 | 2014 | 240 | 0.760 |
Why?
|
| Membrane Glycoproteins | 15 | 2017 | 3702 | 0.750 |
Why?
|
| Blood Coagulation | 9 | 2020 | 1163 | 0.750 |
Why?
|
| Collagen Type IV | 1 | 2021 | 125 | 0.740 |
Why?
|
| Antibodies, Monoclonal | 22 | 2022 | 9245 | 0.740 |
Why?
|
| Mutation | 15 | 2024 | 30211 | 0.740 |
Why?
|
| Cathepsin G | 2 | 2018 | 41 | 0.740 |
Why?
|
| Mast Cells | 13 | 2019 | 1405 | 0.740 |
Why?
|
| Clinical Trials as Topic | 12 | 2024 | 8048 | 0.730 |
Why?
|
| Diabetic Angiopathies | 7 | 2019 | 806 | 0.730 |
Why?
|
| Lipoproteins, HDL | 8 | 2024 | 679 | 0.730 |
Why?
|
| Aorta, Abdominal | 16 | 2020 | 627 | 0.720 |
Why?
|
| Matrix Metalloproteinase 1 | 13 | 2016 | 147 | 0.710 |
Why?
|
| Peptide Hydrolases | 7 | 2017 | 610 | 0.710 |
Why?
|
| Peroxidase | 8 | 2016 | 610 | 0.700 |
Why?
|
| Apoptosis | 25 | 2021 | 9513 | 0.690 |
Why?
|
| Leukocyte Elastase | 3 | 2015 | 113 | 0.670 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 6 | 2017 | 149 | 0.670 |
Why?
|
| Myeloid Cells | 6 | 2021 | 837 | 0.670 |
Why?
|
| Firesetting Behavior | 1 | 2019 | 5 | 0.660 |
Why?
|
| T-Lymphocytes | 26 | 2019 | 10254 | 0.660 |
Why?
|
| Macrophage Activation | 8 | 2022 | 554 | 0.650 |
Why?
|
| Hypertriglyceridemia | 4 | 2022 | 293 | 0.650 |
Why?
|
| Oxidative Stress | 11 | 2020 | 3139 | 0.640 |
Why?
|
| RNA, Messenger | 62 | 2020 | 12793 | 0.640 |
Why?
|
| Thrombin | 6 | 2020 | 600 | 0.640 |
Why?
|
| Receptors, Lipoprotein | 5 | 2002 | 88 | 0.630 |
Why?
|
| Male | 232 | 2024 | 364203 | 0.630 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 13 | 2022 | 2270 | 0.630 |
Why?
|
| Cholesterol, HDL | 15 | 2023 | 1816 | 0.620 |
Why?
|
| NF-kappa B | 22 | 2022 | 2493 | 0.620 |
Why?
|
| Proprotein Convertases | 1 | 2019 | 95 | 0.620 |
Why?
|
| Naproxen | 7 | 2022 | 101 | 0.620 |
Why?
|
| Constriction, Pathologic | 11 | 2021 | 1104 | 0.610 |
Why?
|
| Tomography, Optical Coherence | 12 | 2024 | 2954 | 0.610 |
Why?
|
| Hypercholesterolemia | 17 | 2021 | 1144 | 0.600 |
Why?
|
| Therapies, Investigational | 1 | 2019 | 110 | 0.600 |
Why?
|
| Clone Cells | 2 | 2019 | 1669 | 0.600 |
Why?
|
| Famous Persons | 1 | 2019 | 109 | 0.590 |
Why?
|
| Cysteine Endopeptidases | 9 | 2007 | 542 | 0.590 |
Why?
|
| Diabetes Mellitus, Type 2 | 21 | 2023 | 12250 | 0.580 |
Why?
|
| Biomedical Research | 5 | 2024 | 3464 | 0.580 |
Why?
|
| Enzyme Inhibitors | 4 | 2021 | 3726 | 0.580 |
Why?
|
| Calgranulin B | 6 | 2020 | 87 | 0.580 |
Why?
|
| Music Therapy | 1 | 2019 | 111 | 0.570 |
Why?
|
| Cell Adhesion | 20 | 2020 | 3093 | 0.570 |
Why?
|
| Neutrophil Infiltration | 2 | 2017 | 393 | 0.570 |
Why?
|
| Religion and Medicine | 1 | 2019 | 161 | 0.570 |
Why?
|
| Positron-Emission Tomography | 13 | 2019 | 6550 | 0.570 |
Why?
|
| Hydrolases | 1 | 2018 | 146 | 0.560 |
Why?
|
| Fluorescent Dyes | 10 | 2020 | 1928 | 0.560 |
Why?
|
| Chemokines | 14 | 2023 | 963 | 0.560 |
Why?
|
| Myocarditis | 4 | 2021 | 802 | 0.560 |
Why?
|
| Drug Carriers | 1 | 2021 | 702 | 0.560 |
Why?
|
| Paracrine Communication | 2 | 2018 | 277 | 0.550 |
Why?
|
| Immunity | 4 | 2018 | 1002 | 0.550 |
Why?
|
| Chemokines, CXC | 5 | 2007 | 420 | 0.550 |
Why?
|
| Gene Expression Regulation | 43 | 2021 | 11923 | 0.540 |
Why?
|
| Chemokine CCL2 | 12 | 2015 | 605 | 0.540 |
Why?
|
| Chlamydophila pneumoniae | 6 | 2002 | 53 | 0.540 |
Why?
|
| TRPM Cation Channels | 1 | 2017 | 140 | 0.540 |
Why?
|
| Intercellular Adhesion Molecule-1 | 20 | 2024 | 1132 | 0.530 |
Why?
|
| DNA-Binding Proteins | 17 | 2024 | 9612 | 0.530 |
Why?
|
| Bone Marrow Transplantation | 7 | 2018 | 2710 | 0.530 |
Why?
|
| Adipose Tissue, White | 3 | 2022 | 371 | 0.530 |
Why?
|
| Music | 1 | 2019 | 248 | 0.520 |
Why?
|
| Obesity | 17 | 2019 | 13085 | 0.520 |
Why?
|
| Double-Blind Method | 40 | 2024 | 12451 | 0.520 |
Why?
|
| Matrix Metalloproteinase 8 | 3 | 2014 | 57 | 0.520 |
Why?
|
| Drug Delivery Systems | 4 | 2017 | 2212 | 0.510 |
Why?
|
| Histocompatibility Antigens Class II | 14 | 2017 | 1442 | 0.500 |
Why?
|
| Matrix Metalloproteinase 3 | 14 | 2016 | 139 | 0.500 |
Why?
|
| Immunohistochemistry | 43 | 2021 | 11063 | 0.500 |
Why?
|
| Diagnostic Imaging | 10 | 2012 | 3530 | 0.500 |
Why?
|
| Spectroscopy, Near-Infrared | 7 | 2021 | 749 | 0.490 |
Why?
|
| Disease Progression | 39 | 2021 | 13646 | 0.490 |
Why?
|
| Cathepsin K | 7 | 2018 | 65 | 0.490 |
Why?
|
| Renal Insufficiency, Chronic | 5 | 2022 | 2299 | 0.490 |
Why?
|
| Receptors, CCR2 | 4 | 2015 | 215 | 0.490 |
Why?
|
| Lymphocyte Activation | 18 | 2017 | 5499 | 0.490 |
Why?
|
| Prognosis | 24 | 2024 | 29963 | 0.480 |
Why?
|
| Endothelium | 10 | 2023 | 768 | 0.480 |
Why?
|
| Glucose | 10 | 2022 | 4341 | 0.480 |
Why?
|
| Docosahexaenoic Acids | 9 | 2024 | 914 | 0.480 |
Why?
|
| Bone Marrow | 6 | 2022 | 2926 | 0.480 |
Why?
|
| Ventricular Remodeling | 11 | 2023 | 1281 | 0.470 |
Why?
|
| Ibuprofen | 7 | 2022 | 228 | 0.470 |
Why?
|
| Receptors, Lipoxin | 1 | 2014 | 83 | 0.460 |
Why?
|
| Myelopoiesis | 5 | 2020 | 135 | 0.460 |
Why?
|
| Receptors, Formyl Peptide | 1 | 2014 | 146 | 0.460 |
Why?
|
| Vascular System Injuries | 1 | 2017 | 247 | 0.450 |
Why?
|
| Blood Flow Velocity | 2 | 2017 | 1374 | 0.450 |
Why?
|
| Panniculitis | 1 | 2014 | 45 | 0.450 |
Why?
|
| Apolipoprotein C-III | 9 | 2022 | 209 | 0.450 |
Why?
|
| Transplantation, Homologous | 24 | 2011 | 4838 | 0.440 |
Why?
|
| Granzymes | 1 | 2015 | 277 | 0.440 |
Why?
|
| Aortic Valve | 4 | 2019 | 1968 | 0.440 |
Why?
|
| Proto-Oncogene Proteins | 8 | 2024 | 4522 | 0.440 |
Why?
|
| Th2 Cells | 6 | 2008 | 1077 | 0.440 |
Why?
|
| Arthritis, Rheumatoid | 8 | 2022 | 3778 | 0.440 |
Why?
|
| Desmosine | 2 | 2011 | 19 | 0.440 |
Why?
|
| Chaperonin 60 | 7 | 2010 | 97 | 0.440 |
Why?
|
| Molecular Targeted Therapy | 8 | 2020 | 2824 | 0.440 |
Why?
|
| Leukocytes, Mononuclear | 10 | 2022 | 1854 | 0.430 |
Why?
|
| Foam Cells | 8 | 2011 | 68 | 0.430 |
Why?
|
| Sympathetic Nervous System | 1 | 2016 | 521 | 0.430 |
Why?
|
| Chemotaxis | 5 | 2019 | 598 | 0.430 |
Why?
|
| Rheumatic Diseases | 2 | 2024 | 659 | 0.430 |
Why?
|
| Coronary Vasospasm | 1 | 2013 | 81 | 0.420 |
Why?
|
| Fibrinolysis | 3 | 2015 | 331 | 0.420 |
Why?
|
| Plasminogen | 2 | 2012 | 144 | 0.420 |
Why?
|
| Catheterization, Central Venous | 1 | 2018 | 537 | 0.420 |
Why?
|
| Capillary Permeability | 4 | 2014 | 772 | 0.420 |
Why?
|
| Female | 178 | 2024 | 396660 | 0.410 |
Why?
|
| T-Lymphocyte Subsets | 4 | 2014 | 1814 | 0.400 |
Why?
|
| Cell Division | 25 | 2005 | 4473 | 0.400 |
Why?
|
| Dicarboxylic Acids | 2 | 2024 | 75 | 0.400 |
Why?
|
| Growth Substances | 8 | 1995 | 759 | 0.400 |
Why?
|
| Aged | 104 | 2024 | 171319 | 0.400 |
Why?
|
| Aortic Valve Stenosis | 4 | 2020 | 2021 | 0.400 |
Why?
|
| Receptors, Interleukin-18 | 4 | 2022 | 25 | 0.400 |
Why?
|
| Neovascularization, Pathologic | 5 | 2014 | 2627 | 0.400 |
Why?
|
| Macrophage Colony-Stimulating Factor | 6 | 2022 | 186 | 0.390 |
Why?
|
| Radioactive Tracers | 1 | 2012 | 61 | 0.390 |
Why?
|
| Middle Aged | 114 | 2024 | 223233 | 0.390 |
Why?
|
| Stroke | 18 | 2024 | 9746 | 0.390 |
Why?
|
| Antigens, Ly | 6 | 2019 | 297 | 0.390 |
Why?
|
| Matrix Metalloproteinase 2 | 6 | 2006 | 461 | 0.390 |
Why?
|
| Kidney Failure, Chronic | 3 | 2021 | 2495 | 0.390 |
Why?
|
| Isodesmosine | 1 | 2011 | 6 | 0.390 |
Why?
|
| Adipose Tissue | 8 | 2019 | 3324 | 0.390 |
Why?
|
| Fluorodeoxyglucose F18 | 8 | 2019 | 2028 | 0.390 |
Why?
|
| Matrix Metalloproteinase 12 | 1 | 2011 | 44 | 0.380 |
Why?
|
| Calcinosis | 6 | 2024 | 1481 | 0.380 |
Why?
|
| Platelet Aggregation | 4 | 2021 | 769 | 0.380 |
Why?
|
| Drug Interactions | 4 | 2024 | 1419 | 0.380 |
Why?
|
| Macrophage-1 Antigen | 5 | 2018 | 286 | 0.370 |
Why?
|
| Interleukin-10 | 7 | 2020 | 1182 | 0.370 |
Why?
|
| Heart Failure | 10 | 2024 | 11877 | 0.370 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 3 | 2017 | 319 | 0.360 |
Why?
|
| Risk Assessment | 24 | 2024 | 24299 | 0.360 |
Why?
|
| Microvessels | 2 | 2014 | 585 | 0.360 |
Why?
|
| Mice, Transgenic | 18 | 2024 | 9551 | 0.350 |
Why?
|
| Collagen Type I | 5 | 2022 | 617 | 0.350 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 12 | 2006 | 857 | 0.350 |
Why?
|
| Dinoprostone | 6 | 2015 | 597 | 0.350 |
Why?
|
| RNA, Small Interfering | 10 | 2018 | 3427 | 0.350 |
Why?
|
| Receptors, Chemokine | 7 | 2015 | 652 | 0.350 |
Why?
|
| Disease Susceptibility | 8 | 2022 | 1791 | 0.340 |
Why?
|
| Receptors, CCR1 | 1 | 2009 | 30 | 0.340 |
Why?
|
| Coronary Angiography | 13 | 2024 | 4525 | 0.340 |
Why?
|
| Fibrosis | 10 | 2023 | 2078 | 0.340 |
Why?
|
| Cholesterol, VLDL | 2 | 2009 | 70 | 0.340 |
Why?
|
| Lipoproteins | 7 | 2019 | 871 | 0.330 |
Why?
|
| Reactive Oxygen Species | 8 | 2020 | 2144 | 0.330 |
Why?
|
| NF-kappa B p50 Subunit | 2 | 2008 | 103 | 0.320 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 5 | 2017 | 892 | 0.320 |
Why?
|
| Cathepsin L | 5 | 2020 | 69 | 0.320 |
Why?
|
| Enzyme Activation | 12 | 2015 | 3587 | 0.320 |
Why?
|
| Randomized Controlled Trials as Topic | 11 | 2024 | 10393 | 0.320 |
Why?
|
| Microscopy, Fluorescence | 8 | 2021 | 2628 | 0.320 |
Why?
|
| Primary Prevention | 7 | 2023 | 1188 | 0.320 |
Why?
|
| Fish Oils | 4 | 2023 | 483 | 0.320 |
Why?
|
| Platelet-Derived Growth Factor | 14 | 2005 | 616 | 0.320 |
Why?
|
| Matrix Metalloproteinase 14 | 2 | 2009 | 59 | 0.320 |
Why?
|
| Atrial Fibrillation | 8 | 2024 | 5180 | 0.320 |
Why?
|
| Cell Proliferation | 18 | 2021 | 10455 | 0.320 |
Why?
|
| Acute Disease | 17 | 2024 | 7236 | 0.310 |
Why?
|
| Lymphocytes | 9 | 2023 | 2605 | 0.310 |
Why?
|
| RNA | 5 | 2023 | 2715 | 0.310 |
Why?
|
| Hematopoiesis, Extramedullary | 3 | 2015 | 53 | 0.310 |
Why?
|
| Phospholipids | 5 | 2021 | 778 | 0.310 |
Why?
|
| Lipoproteins, VLDL | 3 | 2007 | 198 | 0.310 |
Why?
|
| Energy Metabolism | 4 | 2019 | 2906 | 0.310 |
Why?
|
| Hyperlipoproteinemia Type II | 2 | 2024 | 396 | 0.310 |
Why?
|
| Lipopolysaccharides | 12 | 2020 | 2217 | 0.310 |
Why?
|
| Predictive Value of Tests | 22 | 2024 | 15424 | 0.310 |
Why?
|
| Interleukins | 6 | 2021 | 796 | 0.300 |
Why?
|
| Adipocytes | 7 | 2020 | 1197 | 0.300 |
Why?
|
| Receptors, Immunologic | 6 | 2002 | 1418 | 0.300 |
Why?
|
| Hypoglycemic Agents | 4 | 2023 | 3108 | 0.300 |
Why?
|
| Coronary Stenosis | 3 | 2005 | 803 | 0.300 |
Why?
|
| Dose-Response Relationship, Drug | 22 | 2020 | 10748 | 0.300 |
Why?
|
| Phenotype | 16 | 2023 | 16718 | 0.300 |
Why?
|
| Nitric Oxide | 11 | 2024 | 2140 | 0.300 |
Why?
|
| Shear Strength | 3 | 2016 | 159 | 0.300 |
Why?
|
| Cell Movement | 18 | 2020 | 5203 | 0.300 |
Why?
|
| Diabetes Complications | 4 | 2020 | 1319 | 0.300 |
Why?
|
| Intra-Abdominal Fat | 2 | 2010 | 624 | 0.290 |
Why?
|
| Mice, Inbred BALB C | 18 | 2020 | 6226 | 0.290 |
Why?
|
| Veins | 4 | 2021 | 769 | 0.290 |
Why?
|
| Gene Expression | 24 | 2019 | 7587 | 0.290 |
Why?
|
| Spleen | 10 | 2017 | 2292 | 0.290 |
Why?
|
| Toll-Like Receptors | 2 | 2011 | 582 | 0.290 |
Why?
|
| Antithrombins | 2 | 2021 | 294 | 0.290 |
Why?
|
| Fatty Acids, Unsaturated | 3 | 2000 | 541 | 0.290 |
Why?
|
| Neoplasms | 6 | 2024 | 22350 | 0.280 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 11 | 2015 | 4572 | 0.280 |
Why?
|
| Hypochlorous Acid | 2 | 2004 | 14 | 0.280 |
Why?
|
| Metformin | 3 | 2005 | 908 | 0.280 |
Why?
|
| Basement Membrane | 3 | 2021 | 348 | 0.280 |
Why?
|
| Medical Oncology | 1 | 2019 | 2341 | 0.280 |
Why?
|
| Serum Albumin, Bovine | 2 | 2011 | 319 | 0.280 |
Why?
|
| Subcutaneous Fat | 1 | 2010 | 403 | 0.270 |
Why?
|
| Gene Deletion | 4 | 2014 | 2668 | 0.270 |
Why?
|
| Phagocytes | 5 | 2009 | 292 | 0.270 |
Why?
|
| Coronavirus Infections | 3 | 2024 | 3112 | 0.270 |
Why?
|
| Diabetes Mellitus, Experimental | 7 | 2021 | 1121 | 0.270 |
Why?
|
| Cell-Derived Microparticles | 2 | 2020 | 159 | 0.270 |
Why?
|
| Diet, Fat-Restricted | 2 | 2000 | 328 | 0.270 |
Why?
|
| Stress, Mechanical | 10 | 2014 | 1673 | 0.270 |
Why?
|
| Pneumonia, Viral | 3 | 2024 | 3234 | 0.270 |
Why?
|
| Flow Cytometry | 19 | 2020 | 5891 | 0.270 |
Why?
|
| E-Selectin | 7 | 2016 | 576 | 0.270 |
Why?
|
| Pancreatic Elastase | 5 | 2011 | 124 | 0.270 |
Why?
|
| Interleukin-4 | 9 | 2023 | 1156 | 0.270 |
Why?
|
| von Willebrand Factor | 1 | 2010 | 680 | 0.270 |
Why?
|
| Chemokine CXCL10 | 6 | 2014 | 311 | 0.260 |
Why?
|
| Fibroblasts | 10 | 2020 | 4167 | 0.260 |
Why?
|
| Membrane Proteins | 10 | 2013 | 7868 | 0.260 |
Why?
|
| Ultrasonography, Interventional | 13 | 2023 | 1523 | 0.260 |
Why?
|
| Calgranulin A | 4 | 2011 | 81 | 0.260 |
Why?
|
| Hematologic Neoplasms | 1 | 2018 | 1907 | 0.260 |
Why?
|
| Blood Platelets | 8 | 2021 | 2464 | 0.260 |
Why?
|
| Radiopharmaceuticals | 7 | 2015 | 2702 | 0.260 |
Why?
|
| Mice, Mutant Strains | 13 | 2015 | 1751 | 0.260 |
Why?
|
| Insulin Resistance | 9 | 2022 | 3986 | 0.260 |
Why?
|
| Models, Immunological | 2 | 2006 | 516 | 0.260 |
Why?
|
| Hyperplasia | 8 | 2021 | 1150 | 0.260 |
Why?
|
| Secondary Prevention | 7 | 2024 | 1472 | 0.260 |
Why?
|
| Recombinant Proteins | 19 | 2015 | 6507 | 0.260 |
Why?
|
| Peripheral Vascular Diseases | 4 | 2014 | 488 | 0.260 |
Why?
|
| Lipoprotein(a) | 3 | 2022 | 488 | 0.260 |
Why?
|
| Angina, Unstable | 5 | 2013 | 893 | 0.260 |
Why?
|
| Chronic Disease | 12 | 2024 | 9362 | 0.260 |
Why?
|
| I-kappa B Proteins | 4 | 2009 | 210 | 0.260 |
Why?
|
| Treatment Outcome | 39 | 2024 | 65295 | 0.250 |
Why?
|
| Chlamydia Infections | 4 | 2002 | 365 | 0.250 |
Why?
|
| Drug Compounding | 2 | 2021 | 236 | 0.250 |
Why?
|
| Adipokines | 1 | 2008 | 309 | 0.250 |
Why?
|
| Oxygen | 2 | 2011 | 4252 | 0.250 |
Why?
|
| Biological Factors | 6 | 2014 | 155 | 0.250 |
Why?
|
| Antigen-Presenting Cells | 6 | 2020 | 960 | 0.250 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2006 | 566 | 0.250 |
Why?
|
| Interleukin-5 | 2 | 2023 | 267 | 0.250 |
Why?
|
| Arthritis | 3 | 2018 | 684 | 0.250 |
Why?
|
| Oxygen Consumption | 3 | 2011 | 1873 | 0.250 |
Why?
|
| Blotting, Western | 14 | 2017 | 5022 | 0.250 |
Why?
|
| Pravastatin | 4 | 2007 | 393 | 0.240 |
Why?
|
| Muscle, Smooth | 7 | 2002 | 930 | 0.240 |
Why?
|
| Publishing | 2 | 2012 | 837 | 0.240 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 4 | 2010 | 279 | 0.240 |
Why?
|
| TNF Receptor-Associated Factor 1 | 3 | 2010 | 48 | 0.240 |
Why?
|
| Tunica Media | 5 | 2009 | 107 | 0.240 |
Why?
|
| Drug Design | 1 | 2010 | 1045 | 0.240 |
Why?
|
| Cell Membrane | 7 | 2021 | 3642 | 0.240 |
Why?
|
| Diffusion of Innovation | 2 | 2020 | 724 | 0.240 |
Why?
|
| Venous Thrombosis | 4 | 2021 | 1321 | 0.230 |
Why?
|
| Leukocyte Count | 4 | 2024 | 1606 | 0.230 |
Why?
|
| Cell Death | 7 | 2020 | 1677 | 0.230 |
Why?
|
| Tissue Distribution | 5 | 2021 | 2275 | 0.230 |
Why?
|
| Antigens, CD | 18 | 2016 | 4032 | 0.230 |
Why?
|
| Serine Endopeptidases | 4 | 2022 | 1027 | 0.230 |
Why?
|
| Vasodilation | 6 | 2010 | 968 | 0.230 |
Why?
|
| Biology | 3 | 2023 | 292 | 0.230 |
Why?
|
| Heart Injuries | 2 | 2021 | 207 | 0.230 |
Why?
|
| Extracellular Matrix Proteins | 5 | 2019 | 832 | 0.230 |
Why?
|
| CD8-Positive T-Lymphocytes | 10 | 2022 | 4648 | 0.230 |
Why?
|
| Gangrene | 1 | 2024 | 92 | 0.230 |
Why?
|
| Time Factors | 37 | 2024 | 40154 | 0.220 |
Why?
|
| Consensus | 6 | 2022 | 3207 | 0.220 |
Why?
|
| Serum Amyloid A Protein | 6 | 2014 | 128 | 0.220 |
Why?
|
| Magnetic Resonance Imaging | 19 | 2023 | 36582 | 0.220 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 5 | 2021 | 2887 | 0.220 |
Why?
|
| Lipid Metabolism Disorders | 1 | 2023 | 20 | 0.220 |
Why?
|
| Gelatinases | 7 | 1999 | 93 | 0.220 |
Why?
|
| Lipid Peroxidation | 2 | 2021 | 276 | 0.220 |
Why?
|
| Neovascularization, Physiologic | 5 | 2015 | 1368 | 0.220 |
Why?
|
| Macaca fascicularis | 3 | 2006 | 908 | 0.220 |
Why?
|
| Aorta, Thoracic | 11 | 2015 | 1110 | 0.220 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 2 | 2017 | 318 | 0.220 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 4 | 2012 | 694 | 0.220 |
Why?
|
| Heart Valve Diseases | 2 | 2022 | 1029 | 0.210 |
Why?
|
| Platelet Activation | 4 | 2005 | 643 | 0.210 |
Why?
|
| Interleukin-8 | 7 | 2014 | 704 | 0.210 |
Why?
|
| MAP Kinase Signaling System | 2 | 2009 | 1492 | 0.210 |
Why?
|
| Tomography, X-Ray Computed | 9 | 2023 | 20741 | 0.210 |
Why?
|
| Acetylcholine | 3 | 2022 | 628 | 0.210 |
Why?
|
| Recurrence | 13 | 2024 | 8504 | 0.210 |
Why?
|
| Tryptophan Oxygenase | 1 | 2002 | 19 | 0.210 |
Why?
|
| Glycoproteins | 10 | 2004 | 2200 | 0.210 |
Why?
|
| Protein Processing, Post-Translational | 5 | 2012 | 1965 | 0.210 |
Why?
|
| Angioplasty, Balloon | 3 | 2008 | 592 | 0.210 |
Why?
|
| Models, Biological | 13 | 2022 | 9464 | 0.210 |
Why?
|
| Isoenzymes | 3 | 2002 | 1688 | 0.210 |
Why?
|
| Coronary Artery Bypass | 3 | 2021 | 2189 | 0.200 |
Why?
|
| Immunity, Cellular | 7 | 2017 | 1560 | 0.200 |
Why?
|
| Chlamydophila Infections | 1 | 2002 | 23 | 0.200 |
Why?
|
| Mice, Congenic | 2 | 2015 | 98 | 0.200 |
Why?
|
| B-Lymphocytes | 7 | 2022 | 4787 | 0.200 |
Why?
|
| Saphenous Vein | 13 | 2007 | 519 | 0.200 |
Why?
|
| Forecasting | 5 | 2020 | 2936 | 0.200 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 2 | 2002 | 319 | 0.200 |
Why?
|
| Immunoglobulin E | 5 | 2020 | 1496 | 0.200 |
Why?
|
| Hypertrophy, Left Ventricular | 3 | 2023 | 856 | 0.200 |
Why?
|
| Sleep Apnea, Obstructive | 3 | 2022 | 1897 | 0.200 |
Why?
|
| Anemia | 2 | 2023 | 1514 | 0.200 |
Why?
|
| Geriatrics | 2 | 2023 | 394 | 0.200 |
Why?
|
| Cardiomegaly | 3 | 2023 | 591 | 0.200 |
Why?
|
| Gout Suppressants | 1 | 2024 | 176 | 0.200 |
Why?
|
| Wound Healing | 7 | 2024 | 2800 | 0.200 |
Why?
|
| Wine | 1 | 2022 | 172 | 0.200 |
Why?
|
| Indocyanine Green | 2 | 2016 | 237 | 0.200 |
Why?
|
| Transcription Factors | 18 | 2015 | 12158 | 0.200 |
Why?
|
| Rejuvenation | 1 | 2003 | 109 | 0.200 |
Why?
|
| Thymosin | 1 | 2022 | 47 | 0.200 |
Why?
|
| Receptors, IgE | 4 | 2020 | 375 | 0.200 |
Why?
|
| Mammary Arteries | 2 | 2021 | 82 | 0.200 |
Why?
|
| Pyridines | 6 | 2016 | 2890 | 0.200 |
Why?
|
| Cardiac Imaging Techniques | 2 | 2021 | 280 | 0.190 |
Why?
|
| Italy | 1 | 2024 | 856 | 0.190 |
Why?
|
| Myocytes, Cardiac | 5 | 2024 | 1672 | 0.190 |
Why?
|
| Protein Binding | 9 | 2022 | 9327 | 0.190 |
Why?
|
| Europe | 3 | 2024 | 3432 | 0.190 |
Why?
|
| Autoimmune Diseases | 4 | 2019 | 2255 | 0.190 |
Why?
|
| Fibric Acids | 1 | 2021 | 27 | 0.190 |
Why?
|
| Ceroid | 1 | 2021 | 6 | 0.190 |
Why?
|
| Kynurenine | 1 | 2002 | 142 | 0.190 |
Why?
|
| Coculture Techniques | 4 | 2018 | 1337 | 0.190 |
Why?
|
| Cromolyn Sodium | 3 | 2019 | 76 | 0.190 |
Why?
|
| Osteoarthritis | 3 | 2018 | 1072 | 0.190 |
Why?
|
| Caspase 1 | 5 | 2021 | 227 | 0.190 |
Why?
|
| Nanotechnology | 2 | 2021 | 702 | 0.180 |
Why?
|
| Hirudins | 2 | 1999 | 179 | 0.180 |
Why?
|
| Stem Cells | 5 | 2012 | 3535 | 0.180 |
Why?
|
| Aspirin | 4 | 2018 | 3135 | 0.180 |
Why?
|
| Angioplasty | 2 | 2016 | 355 | 0.180 |
Why?
|
| Prospective Studies | 25 | 2023 | 54886 | 0.180 |
Why?
|
| Receptors, Retinoic Acid | 2 | 2019 | 229 | 0.180 |
Why?
|
| Neutrophil Activation | 2 | 2021 | 180 | 0.180 |
Why?
|
| Protein Precursors | 3 | 2022 | 1134 | 0.180 |
Why?
|
| Niacin | 1 | 2021 | 116 | 0.180 |
Why?
|
| Cell Differentiation | 15 | 2012 | 11657 | 0.180 |
Why?
|
| Risk | 14 | 2018 | 9606 | 0.180 |
Why?
|
| Atrial Function, Right | 1 | 2020 | 32 | 0.180 |
Why?
|
| Models, Cardiovascular | 6 | 2010 | 978 | 0.180 |
Why?
|
| Vasoconstriction | 3 | 2013 | 591 | 0.180 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 9 | 2017 | 3804 | 0.180 |
Why?
|
| Toll-Like Receptor 4 | 3 | 2015 | 588 | 0.170 |
Why?
|
| Latin America | 1 | 2022 | 416 | 0.170 |
Why?
|
| Diabetic Foot | 1 | 2024 | 382 | 0.170 |
Why?
|
| Germany | 2 | 2020 | 882 | 0.170 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2002 | 1655 | 0.170 |
Why?
|
| Systems Analysis | 1 | 2021 | 168 | 0.170 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2019 | 28 | 0.170 |
Why?
|
| Microbubbles | 2 | 2012 | 137 | 0.170 |
Why?
|
| Vascular Patency | 2 | 2021 | 915 | 0.170 |
Why?
|
| Culture Media, Conditioned | 4 | 2012 | 521 | 0.170 |
Why?
|
| STAT3 Transcription Factor | 3 | 2015 | 872 | 0.170 |
Why?
|
| Static Electricity | 1 | 2020 | 258 | 0.170 |
Why?
|
| Mice, Inbred Strains | 8 | 2009 | 1765 | 0.170 |
Why?
|
| Mice, Obese | 4 | 2015 | 417 | 0.170 |
Why?
|
| Protein Isoforms | 3 | 2016 | 1716 | 0.170 |
Why?
|
| Blood Circulation | 1 | 2021 | 248 | 0.170 |
Why?
|
| Gene Expression Regulation, Enzymologic | 4 | 2009 | 1168 | 0.170 |
Why?
|
| Epidermal Growth Factor | 3 | 2020 | 697 | 0.170 |
Why?
|
| Graft Occlusion, Vascular | 4 | 2004 | 538 | 0.170 |
Why?
|
| Osteogenesis | 4 | 2023 | 1285 | 0.170 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2020 | 111 | 0.170 |
Why?
|
| Age Factors | 7 | 2019 | 18401 | 0.170 |
Why?
|
| Interleukin-3 | 2 | 2019 | 425 | 0.170 |
Why?
|
| Blotting, Northern | 10 | 2001 | 1550 | 0.170 |
Why?
|
| Cell Line | 13 | 2013 | 15567 | 0.170 |
Why?
|
| Ligands | 8 | 2023 | 3273 | 0.160 |
Why?
|
| Gout | 2 | 2018 | 620 | 0.160 |
Why?
|
| Infusions, Intravenous | 4 | 2024 | 2227 | 0.160 |
Why?
|
| Heart | 7 | 2021 | 4429 | 0.160 |
Why?
|
| Retinoids | 1 | 2019 | 99 | 0.160 |
Why?
|
| Adoptive Transfer | 8 | 2020 | 828 | 0.160 |
Why?
|
| Antibodies | 4 | 2021 | 2419 | 0.160 |
Why?
|
| Transforming Growth Factor beta | 6 | 2023 | 1995 | 0.160 |
Why?
|
| Enzyme Induction | 8 | 2011 | 455 | 0.160 |
Why?
|
| Menopause, Premature | 1 | 2020 | 124 | 0.160 |
Why?
|
| DNA Primers | 5 | 2010 | 2827 | 0.160 |
Why?
|
| Methotrexate | 2 | 2018 | 1718 | 0.160 |
Why?
|
| Apolipoproteins B | 5 | 2014 | 385 | 0.160 |
Why?
|
| Vascular Grafting | 1 | 2021 | 163 | 0.160 |
Why?
|
| Thrombospondin 1 | 1 | 2001 | 257 | 0.160 |
Why?
|
| Antibody-Producing Cells | 1 | 2019 | 140 | 0.160 |
Why?
|
| Endotoxemia | 1 | 2020 | 198 | 0.160 |
Why?
|
| Scavenger Receptors, Class B | 5 | 2002 | 85 | 0.160 |
Why?
|
| Cystatins | 3 | 2005 | 55 | 0.160 |
Why?
|
| Enalapril | 3 | 2013 | 317 | 0.160 |
Why?
|
| Leukocytosis | 3 | 2021 | 248 | 0.160 |
Why?
|
| History, 17th Century | 1 | 2019 | 108 | 0.160 |
Why?
|
| Fibrinogen | 4 | 2022 | 892 | 0.160 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2021 | 547 | 0.160 |
Why?
|
| Leukemia L1210 | 2 | 1989 | 44 | 0.160 |
Why?
|
| Drug Tolerance | 1 | 2020 | 365 | 0.160 |
Why?
|
| Ultrasonography | 10 | 2017 | 6000 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 2019 | 82 | 0.160 |
Why?
|
| Receptors, Scavenger | 5 | 2002 | 123 | 0.160 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-3 | 1 | 1998 | 34 | 0.160 |
Why?
|
| Phosphorylation | 7 | 2016 | 8310 | 0.160 |
Why?
|
| Renal Replacement Therapy | 1 | 2021 | 281 | 0.160 |
Why?
|
| Amlodipine | 2 | 2012 | 84 | 0.160 |
Why?
|
| Surface Properties | 1 | 2021 | 1154 | 0.160 |
Why?
|
| History, 18th Century | 1 | 2019 | 206 | 0.160 |
Why?
|
| Ascorbic Acid | 1 | 2002 | 658 | 0.150 |
Why?
|
| Muscle Proteins | 5 | 1984 | 1160 | 0.150 |
Why?
|
| Magnetic Resonance Angiography | 3 | 2014 | 1429 | 0.150 |
Why?
|
| Histocytochemistry | 4 | 2009 | 697 | 0.150 |
Why?
|
| Cysteine Proteases | 1 | 2018 | 13 | 0.150 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 5 | 2011 | 1142 | 0.150 |
Why?
|
| Kinetics | 12 | 2012 | 6287 | 0.150 |
Why?
|
| Spermine | 4 | 1989 | 70 | 0.150 |
Why?
|
| Adenosine | 1 | 2023 | 812 | 0.150 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2019 | 224 | 0.150 |
Why?
|
| Cell Degranulation | 1 | 2019 | 276 | 0.150 |
Why?
|
| Atrial Flutter | 1 | 2020 | 253 | 0.150 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 5 | 1995 | 97 | 0.150 |
Why?
|
| Base Sequence | 14 | 2007 | 12414 | 0.150 |
Why?
|
| Thermogenesis | 1 | 2022 | 495 | 0.150 |
Why?
|
| Endothelin-1 | 1 | 2019 | 296 | 0.150 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2020 | 1244 | 0.150 |
Why?
|
| Endothelins | 2 | 2020 | 127 | 0.150 |
Why?
|
| History, 20th Century | 2 | 2019 | 2765 | 0.150 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2021 | 2764 | 0.150 |
Why?
|
| Species Specificity | 2 | 2015 | 2412 | 0.150 |
Why?
|
| Drug-Eluting Stents | 1 | 2024 | 681 | 0.150 |
Why?
|
| Acetyltransferases | 3 | 1989 | 230 | 0.150 |
Why?
|
| Heart Function Tests | 1 | 2018 | 316 | 0.150 |
Why?
|
| Coronary Circulation | 3 | 2013 | 1603 | 0.150 |
Why?
|
| Diet | 4 | 2021 | 8089 | 0.150 |
Why?
|
| Jugular Veins | 2 | 2020 | 211 | 0.150 |
Why?
|
| Vena Cava, Inferior | 1 | 2021 | 463 | 0.150 |
Why?
|
| Estrogen Receptor alpha | 1 | 2022 | 581 | 0.150 |
Why?
|
| Gene Expression Profiling | 8 | 2021 | 9532 | 0.140 |
Why?
|
| Oligodeoxyribonucleotides | 4 | 2012 | 705 | 0.140 |
Why?
|
| Protease Inhibitors | 7 | 2015 | 750 | 0.140 |
Why?
|
| Incidence | 15 | 2024 | 21526 | 0.140 |
Why?
|
| Mice, 129 Strain | 3 | 2016 | 367 | 0.140 |
Why?
|
| Thiazolidinediones | 4 | 2003 | 460 | 0.140 |
Why?
|
| United States | 21 | 2023 | 72971 | 0.140 |
Why?
|
| Severity of Illness Index | 6 | 2021 | 15925 | 0.140 |
Why?
|
| Fibronectins | 3 | 2018 | 722 | 0.140 |
Why?
|
| Deoxyribonuclease I | 1 | 2018 | 228 | 0.140 |
Why?
|
| Chlamydia trachomatis | 1 | 1999 | 239 | 0.140 |
Why?
|
| Fibrin | 1 | 2020 | 514 | 0.140 |
Why?
|
| Contrast Media | 6 | 2014 | 5329 | 0.140 |
Why?
|
| Immunosuppressive Agents | 5 | 2018 | 4210 | 0.140 |
Why?
|
| Lymphocyte Culture Test, Mixed | 8 | 2017 | 511 | 0.140 |
Why?
|
| Receptors, IgG | 3 | 2016 | 563 | 0.140 |
Why?
|
| Sirolimus | 1 | 2024 | 1539 | 0.140 |
Why?
|
| Myosin Heavy Chains | 1 | 1998 | 403 | 0.140 |
Why?
|
| Muscles | 6 | 1981 | 1576 | 0.140 |
Why?
|
| Permeability | 1 | 2019 | 721 | 0.140 |
Why?
|
| Fibroblast Growth Factors | 4 | 1993 | 873 | 0.140 |
Why?
|
| Dendritic Cells | 4 | 2023 | 2745 | 0.140 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2017 | 88 | 0.140 |
Why?
|
| Mitogens | 2 | 1988 | 229 | 0.140 |
Why?
|
| Ribonucleases | 3 | 2023 | 266 | 0.140 |
Why?
|
| Organ Transplantation | 1 | 2007 | 1173 | 0.140 |
Why?
|
| Oxazines | 2 | 2016 | 358 | 0.140 |
Why?
|
| Immunoblotting | 3 | 2016 | 1647 | 0.140 |
Why?
|
| Immunoglobulin M | 3 | 2019 | 1527 | 0.140 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2020 | 291 | 0.130 |
Why?
|
| Leupeptins | 4 | 1981 | 113 | 0.130 |
Why?
|
| Enzyme Precursors | 2 | 2008 | 166 | 0.130 |
Why?
|
| Drug Approval | 4 | 2020 | 820 | 0.130 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2017 | 146 | 0.130 |
Why?
|
| Atrial Appendage | 1 | 2020 | 285 | 0.130 |
Why?
|
| Cardiac Surgical Procedures | 4 | 2020 | 3683 | 0.130 |
Why?
|
| Intestine, Small | 2 | 2019 | 1217 | 0.130 |
Why?
|
| Cell Cycle Proteins | 1 | 2008 | 3440 | 0.130 |
Why?
|
| Apolipoproteins C | 2 | 2006 | 59 | 0.130 |
Why?
|
| Blood Pressure | 8 | 2019 | 8531 | 0.130 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 2 | 2016 | 301 | 0.130 |
Why?
|
| Dilatation, Pathologic | 4 | 2020 | 527 | 0.130 |
Why?
|
| Cystatin C | 5 | 2010 | 272 | 0.130 |
Why?
|
| Mass Screening | 3 | 2023 | 5456 | 0.130 |
Why?
|
| Drug Therapy | 1 | 2019 | 504 | 0.130 |
Why?
|
| Hypertension | 7 | 2021 | 8615 | 0.130 |
Why?
|
| Pneumonia | 3 | 2019 | 2159 | 0.130 |
Why?
|
| Anticoagulants | 3 | 2016 | 4854 | 0.130 |
Why?
|
| Ricinoleic Acids | 1 | 1995 | 1 | 0.130 |
Why?
|
| Physical Conditioning, Animal | 1 | 2019 | 363 | 0.130 |
Why?
|
| STAT4 Transcription Factor | 2 | 2012 | 94 | 0.130 |
Why?
|
| Adipogenesis | 2 | 2010 | 370 | 0.130 |
Why?
|
| Models, Animal | 4 | 2015 | 2121 | 0.130 |
Why?
|
| Cyclosporine | 2 | 1995 | 778 | 0.130 |
Why?
|
| Caspases | 2 | 2015 | 881 | 0.130 |
Why?
|
| Organ Culture Techniques | 4 | 2008 | 789 | 0.130 |
Why?
|
| Aged, 80 and over | 18 | 2021 | 59548 | 0.130 |
Why?
|
| Periodicals as Topic | 3 | 2024 | 1465 | 0.130 |
Why?
|
| Investments | 1 | 2017 | 148 | 0.130 |
Why?
|
| Iliac Artery | 4 | 2008 | 344 | 0.130 |
Why?
|
| 3T3-L1 Cells | 3 | 2015 | 207 | 0.130 |
Why?
|
| Fibrinolytic Agents | 3 | 2020 | 2079 | 0.130 |
Why?
|
| Oligopeptides | 6 | 1998 | 1195 | 0.120 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2018 | 283 | 0.120 |
Why?
|
| Dextrans | 2 | 2014 | 574 | 0.120 |
Why?
|
| Procollagen | 3 | 2013 | 189 | 0.120 |
Why?
|
| Antioxidants | 2 | 2019 | 1671 | 0.120 |
Why?
|
| Immunomodulation | 1 | 2019 | 548 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 10 | 2022 | 18063 | 0.120 |
Why?
|
| Pancreas | 1 | 2022 | 1699 | 0.120 |
Why?
|
| Transplantation, Heterotopic | 4 | 2009 | 175 | 0.120 |
Why?
|
| Transcription Factor CHOP | 1 | 2015 | 69 | 0.120 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2015 | 127 | 0.120 |
Why?
|
| Graft Survival | 10 | 2021 | 3896 | 0.120 |
Why?
|
| Insulin-Secreting Cells | 1 | 2022 | 898 | 0.120 |
Why?
|
| History, 21st Century | 2 | 2019 | 1574 | 0.120 |
Why?
|
| Cytomegalovirus Infections | 1 | 2001 | 836 | 0.120 |
Why?
|
| Fluoresceins | 1 | 2015 | 235 | 0.120 |
Why?
|
| Gingiva | 1 | 2017 | 422 | 0.120 |
Why?
|
| Postoperative Hemorrhage | 1 | 2018 | 418 | 0.120 |
Why?
|
| Drug Discovery | 2 | 2015 | 1068 | 0.120 |
Why?
|
| Rupture | 3 | 2009 | 444 | 0.120 |
Why?
|
| Heart Arrest | 2 | 2024 | 1516 | 0.120 |
Why?
|
| Myocardial Reperfusion Injury | 3 | 2014 | 483 | 0.120 |
Why?
|
| Actins | 7 | 2013 | 2059 | 0.120 |
Why?
|
| Lung Diseases | 2 | 2024 | 1942 | 0.120 |
Why?
|
| Heart Ventricles | 9 | 2019 | 3837 | 0.120 |
Why?
|
| Protein Phosphatase 1 | 1 | 2015 | 135 | 0.120 |
Why?
|
| Metabolic Diseases | 1 | 2021 | 684 | 0.120 |
Why?
|
| Immunotherapy | 2 | 2021 | 4745 | 0.120 |
Why?
|
| Postoperative Complications | 9 | 2015 | 15824 | 0.120 |
Why?
|
| Hemorrhage | 4 | 2016 | 3464 | 0.120 |
Why?
|
| Blood Glucose | 5 | 2020 | 6421 | 0.110 |
Why?
|
| Leptin | 2 | 2015 | 1599 | 0.110 |
Why?
|
| Solubility | 6 | 2006 | 1078 | 0.110 |
Why?
|
| Polymerase Chain Reaction | 10 | 2010 | 6067 | 0.110 |
Why?
|
| P-Selectin | 4 | 2016 | 598 | 0.110 |
Why?
|
| Apolipoprotein B-100 | 2 | 2006 | 157 | 0.110 |
Why?
|
| Injections, Subcutaneous | 3 | 2021 | 685 | 0.110 |
Why?
|
| Dietary Fats | 3 | 2011 | 2001 | 0.110 |
Why?
|
| Serum Amyloid P-Component | 1 | 2014 | 46 | 0.110 |
Why?
|
| Periodontitis | 2 | 2009 | 576 | 0.110 |
Why?
|
| Ergonovine | 1 | 2013 | 14 | 0.110 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2014 | 67 | 0.110 |
Why?
|
| Catheterization | 3 | 2008 | 1430 | 0.110 |
Why?
|
| PPAR gamma | 4 | 2015 | 484 | 0.110 |
Why?
|
| Societies, Medical | 2 | 2024 | 3964 | 0.110 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2015 | 271 | 0.110 |
Why?
|
| Osteomyelitis | 1 | 2018 | 408 | 0.110 |
Why?
|
| In Situ Hybridization | 3 | 2003 | 1892 | 0.110 |
Why?
|
| Macrophage Migration-Inhibitory Factors | 2 | 2004 | 109 | 0.110 |
Why?
|
| Interferon Regulatory Factors | 2 | 2013 | 271 | 0.110 |
Why?
|
| Interferon Type I | 1 | 2017 | 568 | 0.110 |
Why?
|
| Blood Vessel Prosthesis | 4 | 1989 | 956 | 0.110 |
Why?
|
| Proteins | 7 | 2009 | 6001 | 0.110 |
Why?
|
| Gene Silencing | 2 | 2011 | 1505 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2005 | 3449 | 0.110 |
Why?
|
| Disease Management | 3 | 2020 | 2531 | 0.110 |
Why?
|
| Receptors, Endothelin | 1 | 1993 | 56 | 0.110 |
Why?
|
| Life Style | 3 | 2019 | 3931 | 0.110 |
Why?
|
| Chemokine CCL5 | 3 | 2009 | 214 | 0.110 |
Why?
|
| Osteoclasts | 1 | 2017 | 713 | 0.110 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2017 | 2160 | 0.110 |
Why?
|
| Annexin A5 | 1 | 2013 | 102 | 0.110 |
Why?
|
| Immunoglobulin Variable Region | 1 | 1994 | 419 | 0.110 |
Why?
|
| Histones | 9 | 2014 | 2597 | 0.110 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2013 | 72 | 0.110 |
Why?
|
| Oxytocics | 1 | 2013 | 67 | 0.110 |
Why?
|
| Linear Models | 4 | 2018 | 5875 | 0.110 |
Why?
|
| Nanomedicine | 2 | 2013 | 289 | 0.100 |
Why?
|
| Proteomics | 6 | 2023 | 3913 | 0.100 |
Why?
|
| Stents | 6 | 2022 | 3193 | 0.100 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 1993 | 194 | 0.100 |
Why?
|
| Magnetite Nanoparticles | 1 | 2014 | 310 | 0.100 |
Why?
|
| Immunity, Humoral | 1 | 2017 | 610 | 0.100 |
Why?
|
| T-Box Domain Proteins | 2 | 2012 | 471 | 0.100 |
Why?
|
| Epigenomics | 1 | 2018 | 959 | 0.100 |
Why?
|
| Odds Ratio | 9 | 2018 | 9660 | 0.100 |
Why?
|
| Aortic Rupture | 1 | 2016 | 322 | 0.100 |
Why?
|
| Hyaluronic Acid | 2 | 2015 | 484 | 0.100 |
Why?
|
| Fibroblast Growth Factor 2 | 4 | 1997 | 590 | 0.100 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 2 | 2011 | 325 | 0.100 |
Why?
|
| Genes, fms | 1 | 1992 | 6 | 0.100 |
Why?
|
| Follow-Up Studies | 15 | 2021 | 39317 | 0.100 |
Why?
|
| Radiation Chimera | 2 | 2014 | 216 | 0.100 |
Why?
|
| Genetic Markers | 1 | 2018 | 2602 | 0.100 |
Why?
|
| Proportional Hazards Models | 9 | 2019 | 12536 | 0.100 |
Why?
|
| Cysteine Proteinase Inhibitors | 4 | 2018 | 185 | 0.100 |
Why?
|
| Stress, Physiological | 3 | 2015 | 1407 | 0.100 |
Why?
|
| Gastrointestinal Diseases | 2 | 2018 | 1205 | 0.100 |
Why?
|
| DNA Damage | 2 | 2020 | 2469 | 0.100 |
Why?
|
| American Heart Association | 1 | 2017 | 1049 | 0.100 |
Why?
|
| Uric Acid | 1 | 2018 | 805 | 0.100 |
Why?
|
| Sensitivity and Specificity | 9 | 2016 | 14672 | 0.100 |
Why?
|
| Longevity | 1 | 2020 | 1083 | 0.100 |
Why?
|
| Cell Survival | 6 | 2015 | 5750 | 0.100 |
Why?
|
| Cyclooxygenase Inhibitors | 3 | 2009 | 361 | 0.100 |
Why?
|
| Cell Transdifferentiation | 1 | 2013 | 186 | 0.100 |
Why?
|
| Polyamines | 2 | 1989 | 132 | 0.100 |
Why?
|
| Neointima | 3 | 2021 | 133 | 0.100 |
Why?
|
| Autoimmunity | 2 | 2017 | 1361 | 0.100 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-2 | 3 | 1998 | 71 | 0.100 |
Why?
|
| Mice, Inbred DBA | 2 | 2010 | 624 | 0.100 |
Why?
|
| Cell Hypoxia | 1 | 2014 | 661 | 0.100 |
Why?
|
| Cyclooxygenase 2 | 3 | 2012 | 597 | 0.100 |
Why?
|
| Swine | 6 | 2021 | 5987 | 0.100 |
Why?
|
| Tetradecanoylphorbol Acetate | 5 | 2007 | 826 | 0.100 |
Why?
|
| Peptide Fragments | 3 | 2020 | 5141 | 0.100 |
Why?
|
| Random Allocation | 4 | 2020 | 2394 | 0.100 |
Why?
|
| Heart Conduction System | 1 | 2017 | 1008 | 0.090 |
Why?
|
| Dietary Supplements | 3 | 2020 | 3446 | 0.090 |
Why?
|
| Rats | 18 | 2010 | 23713 | 0.090 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 5 | 2007 | 281 | 0.090 |
Why?
|
| Patient Discharge | 1 | 2024 | 3467 | 0.090 |
Why?
|
| Patient Admission | 1 | 2019 | 1364 | 0.090 |
Why?
|
| HLA Antigens | 3 | 1993 | 1334 | 0.090 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2012 | 193 | 0.090 |
Why?
|
| Postmenopause | 1 | 2020 | 2518 | 0.090 |
Why?
|
| Myofibroblasts | 1 | 2013 | 230 | 0.090 |
Why?
|
| Renal Dialysis | 1 | 2021 | 1790 | 0.090 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2022 | 1665 | 0.090 |
Why?
|
| Hyperglycemia | 3 | 2006 | 1388 | 0.090 |
Why?
|
| Statistics, Nonparametric | 3 | 2018 | 2850 | 0.090 |
Why?
|
| Arteriovenous Fistula | 1 | 2014 | 320 | 0.090 |
Why?
|
| Adult | 33 | 2023 | 223317 | 0.090 |
Why?
|
| Receptors, Cholinergic | 3 | 1981 | 243 | 0.090 |
Why?
|
| Pancreatitis | 1 | 2018 | 1087 | 0.090 |
Why?
|
| Precancerous Conditions | 1 | 2018 | 980 | 0.090 |
Why?
|
| Vasoconstrictor Agents | 2 | 2013 | 655 | 0.090 |
Why?
|
| Exercise | 2 | 2019 | 5954 | 0.090 |
Why?
|
| Molecular Sequence Data | 11 | 1996 | 17608 | 0.090 |
Why?
|
| Transplantation, Isogeneic | 2 | 2009 | 249 | 0.090 |
Why?
|
| Lower Extremity | 2 | 2016 | 1217 | 0.090 |
Why?
|
| Heparin | 2 | 2016 | 1636 | 0.090 |
Why?
|
| Fluorescence | 3 | 2011 | 751 | 0.090 |
Why?
|
| Norepinephrine | 2 | 2013 | 898 | 0.090 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2017 | 3114 | 0.090 |
Why?
|
| Repressor Proteins | 2 | 2019 | 2979 | 0.090 |
Why?
|
| Hemodynamics | 3 | 2019 | 4186 | 0.090 |
Why?
|
| Ovalbumin | 4 | 2016 | 677 | 0.090 |
Why?
|
| Interleukin-13 | 2 | 2023 | 391 | 0.090 |
Why?
|
| Syndrome | 6 | 2003 | 3271 | 0.090 |
Why?
|
| Histocompatibility Antigens Class I | 3 | 2022 | 1362 | 0.090 |
Why?
|
| Chloroquine | 3 | 1981 | 276 | 0.090 |
Why?
|
| Calcium | 6 | 2017 | 5792 | 0.090 |
Why?
|
| Angioplasty, Balloon, Coronary | 2 | 1995 | 1721 | 0.090 |
Why?
|
| Receptors, Interferon | 2 | 2008 | 115 | 0.090 |
Why?
|
| Cryopreservation | 2 | 2006 | 727 | 0.090 |
Why?
|
| Isoquinolines | 1 | 2012 | 349 | 0.090 |
Why?
|
| Major Histocompatibility Complex | 2 | 1993 | 879 | 0.090 |
Why?
|
| Antigen Presentation | 3 | 2017 | 1250 | 0.090 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1994 | 812 | 0.090 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2010 | 57 | 0.090 |
Why?
|
| Immunoenzyme Techniques | 6 | 2000 | 1697 | 0.090 |
Why?
|
| Venous Thromboembolism | 3 | 2014 | 1883 | 0.090 |
Why?
|
| Granulocytes | 2 | 2011 | 551 | 0.090 |
Why?
|
| DNA | 9 | 2022 | 7210 | 0.090 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2024 | 706 | 0.090 |
Why?
|
| Peripheral Arterial Disease | 2 | 2024 | 1304 | 0.090 |
Why?
|
| Hydrolysis | 1 | 2011 | 645 | 0.090 |
Why?
|
| Antibodies, Neutralizing | 1 | 2020 | 2011 | 0.090 |
Why?
|
| Animal Feed | 2 | 2008 | 105 | 0.090 |
Why?
|
| Interferon-beta | 1 | 1992 | 348 | 0.090 |
Why?
|
| Simvastatin | 2 | 2002 | 345 | 0.090 |
Why?
|
| Receptors, GABA | 1 | 2012 | 312 | 0.090 |
Why?
|
| Structure-Activity Relationship | 4 | 2022 | 3052 | 0.090 |
Why?
|
| Tryptases | 1 | 2011 | 175 | 0.090 |
Why?
|
| Hexokinase | 1 | 2010 | 124 | 0.090 |
Why?
|
| Kidney Diseases | 2 | 2018 | 2099 | 0.090 |
Why?
|
| Prevalence | 3 | 2021 | 15851 | 0.090 |
Why?
|
| Health Status | 2 | 2021 | 4091 | 0.090 |
Why?
|
| Ischemia | 6 | 2024 | 1905 | 0.080 |
Why?
|
| Allergy and Immunology | 1 | 2011 | 170 | 0.080 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 1 | 2010 | 144 | 0.080 |
Why?
|
| Femoral Artery | 2 | 2009 | 827 | 0.080 |
Why?
|
| Deoxyglucose | 1 | 2010 | 322 | 0.080 |
Why?
|
| Chymases | 1 | 2009 | 84 | 0.080 |
Why?
|
| Transfection | 8 | 2007 | 5753 | 0.080 |
Why?
|
| Polyethylene Glycols | 1 | 1995 | 1188 | 0.080 |
Why?
|
| Dementia | 1 | 2024 | 2741 | 0.080 |
Why?
|
| Heart Rate | 5 | 2020 | 4209 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factors | 2 | 2001 | 748 | 0.080 |
Why?
|
| Protein Kinase C-alpha | 2 | 2006 | 113 | 0.080 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 3 | 2013 | 1515 | 0.080 |
Why?
|
| Pertussis Toxin | 2 | 2006 | 176 | 0.080 |
Why?
|
| Amino Acid Motifs | 2 | 2011 | 928 | 0.080 |
Why?
|
| RNA Interference | 5 | 2016 | 2829 | 0.080 |
Why?
|
| Polyethylene Terephthalates | 2 | 1986 | 112 | 0.080 |
Why?
|
| Hemostasis | 2 | 1989 | 467 | 0.080 |
Why?
|
| Air Pollution | 1 | 2023 | 2378 | 0.080 |
Why?
|
| Antihypertensive Agents | 2 | 2012 | 2030 | 0.080 |
Why?
|
| Serpins | 2 | 2001 | 246 | 0.080 |
Why?
|
| Morbidity | 2 | 2018 | 1754 | 0.080 |
Why?
|
| Corn Oil | 2 | 2023 | 29 | 0.080 |
Why?
|
| Endotoxins | 3 | 2000 | 519 | 0.080 |
Why?
|
| Adaptation, Physiological | 2 | 2014 | 1312 | 0.080 |
Why?
|
| Communicable Diseases | 1 | 2017 | 872 | 0.080 |
Why?
|
| Congresses as Topic | 2 | 2015 | 812 | 0.080 |
Why?
|
| Cattle | 8 | 2011 | 3813 | 0.080 |
Why?
|
| Case-Control Studies | 11 | 2022 | 22254 | 0.080 |
Why?
|
| Cicatrix | 1 | 2015 | 798 | 0.080 |
Why?
|
| Receptors, Tumor Necrosis Factor | 2 | 2003 | 588 | 0.080 |
Why?
|
| Smad3 Protein | 3 | 2019 | 166 | 0.080 |
Why?
|
| Lymphotoxin-alpha | 1 | 1989 | 94 | 0.080 |
Why?
|
| Transcription, Genetic | 10 | 2020 | 7611 | 0.080 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2016 | 2428 | 0.080 |
Why?
|
| Endothelial Growth Factors | 2 | 2001 | 671 | 0.080 |
Why?
|
| Immunoglobulin G | 5 | 2017 | 4560 | 0.080 |
Why?
|
| Gene Regulatory Networks | 3 | 2023 | 1752 | 0.080 |
Why?
|
| Embryonic Stem Cells | 1 | 2015 | 1244 | 0.080 |
Why?
|
| Fasting | 1 | 2014 | 1607 | 0.080 |
Why?
|
| Transforming Growth Factor beta1 | 4 | 2019 | 637 | 0.080 |
Why?
|
| Myocardial Revascularization | 3 | 2023 | 795 | 0.080 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2009 | 98 | 0.080 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2007 | 2883 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-kit | 2 | 2009 | 723 | 0.080 |
Why?
|
| Receptor, Angiotensin, Type 2 | 2 | 2005 | 61 | 0.080 |
Why?
|
| Multivariate Analysis | 5 | 2014 | 12069 | 0.080 |
Why?
|
| Stimulation, Chemical | 5 | 1995 | 305 | 0.070 |
Why?
|
| Biological Transport | 3 | 2010 | 2084 | 0.070 |
Why?
|
| Hemoglobins | 3 | 2023 | 1531 | 0.070 |
Why?
|
| Lymphokines | 2 | 2001 | 924 | 0.070 |
Why?
|
| Fibroblast Growth Factor 1 | 2 | 2001 | 53 | 0.070 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2009 | 306 | 0.070 |
Why?
|
| Blood Proteins | 2 | 2023 | 1190 | 0.070 |
Why?
|
| Internet | 1 | 2020 | 3114 | 0.070 |
Why?
|
| Chemokine CXCL11 | 3 | 2002 | 42 | 0.070 |
Why?
|
| Ketotifen | 2 | 2019 | 24 | 0.070 |
Why?
|
| Texas | 2 | 2007 | 410 | 0.070 |
Why?
|
| MAP Kinase Kinase 2 | 1 | 2008 | 92 | 0.070 |
Why?
|
| Reproducibility of Results | 7 | 2016 | 20169 | 0.070 |
Why?
|
| Nuclear Proteins | 2 | 2015 | 5794 | 0.070 |
Why?
|
| Glucagon-Like Peptide 1 | 2 | 2022 | 374 | 0.070 |
Why?
|
| Autacoids | 1 | 2007 | 17 | 0.070 |
Why?
|
| Capillaries | 2 | 2003 | 755 | 0.070 |
Why?
|
| Catheterization, Peripheral | 1 | 2011 | 346 | 0.070 |
Why?
|
| Antiviral Agents | 1 | 2020 | 3070 | 0.070 |
Why?
|
| Administration, Oral | 4 | 2023 | 4026 | 0.070 |
Why?
|
| Chromans | 3 | 2003 | 116 | 0.070 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 440 | 0.070 |
Why?
|
| Chromatography, Liquid | 2 | 2022 | 996 | 0.070 |
Why?
|
| Chemotactic Factors | 2 | 2022 | 197 | 0.070 |
Why?
|
| TNF Receptor-Associated Factor 5 | 1 | 2007 | 5 | 0.070 |
Why?
|
| Drug Therapy, Combination | 4 | 2021 | 6310 | 0.070 |
Why?
|
| Receptors, Cell Surface | 4 | 2005 | 2815 | 0.070 |
Why?
|
| Editorial Policies | 1 | 2012 | 458 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 8 | 2009 | 5796 | 0.070 |
Why?
|
| Chemokine CXCL9 | 3 | 2002 | 135 | 0.070 |
Why?
|
| Indomethacin | 3 | 1996 | 323 | 0.070 |
Why?
|
| Drug Industry | 2 | 2015 | 791 | 0.070 |
Why?
|
| Sus scrofa | 2 | 2021 | 430 | 0.070 |
Why?
|
| Endpoint Determination | 2 | 2009 | 592 | 0.070 |
Why?
|
| TNF Receptor-Associated Factor 3 | 1 | 2007 | 38 | 0.070 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 1 | 1987 | 62 | 0.070 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2013 | 1164 | 0.070 |
Why?
|
| Transplants | 1 | 2009 | 208 | 0.070 |
Why?
|
| Macrophages, Peritoneal | 4 | 2013 | 244 | 0.070 |
Why?
|
| Substrate Specificity | 4 | 2004 | 1750 | 0.070 |
Why?
|
| TNF Receptor-Associated Factor 2 | 1 | 2007 | 56 | 0.070 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 2 | 2011 | 117 | 0.070 |
Why?
|
| TNF Receptor-Associated Factor 6 | 1 | 2007 | 61 | 0.070 |
Why?
|
| Pandemics | 3 | 2024 | 8736 | 0.070 |
Why?
|
| Up-Regulation | 3 | 2014 | 4143 | 0.070 |
Why?
|
| Vaccination | 1 | 2019 | 3434 | 0.070 |
Why?
|
| Immunophenotyping | 2 | 2015 | 1864 | 0.070 |
Why?
|
| Frozen Sections | 2 | 1999 | 153 | 0.070 |
Why?
|
| Hypersensitivity | 1 | 2016 | 1169 | 0.070 |
Why?
|
| Postoperative Care | 1 | 2013 | 1480 | 0.070 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2007 | 267 | 0.070 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2020 | 2478 | 0.070 |
Why?
|
| Schistosomiasis mansoni | 1 | 1987 | 94 | 0.070 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2006 | 63 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2022 | 3511 | 0.070 |
Why?
|
| Magnetics | 1 | 2009 | 586 | 0.070 |
Why?
|
| Prostaglandins I | 1 | 2006 | 12 | 0.070 |
Why?
|
| HIV Infections | 2 | 2024 | 17542 | 0.070 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2008 | 330 | 0.070 |
Why?
|
| Metal Nanoparticles | 1 | 2010 | 400 | 0.070 |
Why?
|
| Anti-Allergic Agents | 2 | 2019 | 153 | 0.060 |
Why?
|
| Smad2 Protein | 2 | 2019 | 144 | 0.060 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 1993 | 1621 | 0.060 |
Why?
|
| Immunologic Factors | 2 | 2020 | 1592 | 0.060 |
Why?
|
| Polymorphism, Genetic | 3 | 2005 | 4247 | 0.060 |
Why?
|
| Th17 Cells | 1 | 2012 | 790 | 0.060 |
Why?
|
| Endosomes | 1 | 2009 | 521 | 0.060 |
Why?
|
| Cytomegalovirus | 2 | 2001 | 751 | 0.060 |
Why?
|
| Stem Cell Niche | 2 | 2022 | 347 | 0.060 |
Why?
|
| Oxidation-Reduction | 5 | 2014 | 2221 | 0.060 |
Why?
|
| North America | 2 | 2024 | 1287 | 0.060 |
Why?
|
| Sialic Acids | 1 | 1986 | 122 | 0.060 |
Why?
|
| Drug Administration Schedule | 3 | 2018 | 4855 | 0.060 |
Why?
|
| ROC Curve | 3 | 2024 | 3618 | 0.060 |
Why?
|
| Homeodomain Proteins | 2 | 2019 | 2429 | 0.060 |
Why?
|
| Molecular Weight | 3 | 1998 | 2168 | 0.060 |
Why?
|
| Neuraminidase | 1 | 1986 | 192 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2024 | 6513 | 0.060 |
Why?
|
| Polytetrafluoroethylene | 1 | 1986 | 242 | 0.060 |
Why?
|
| Cohort Studies | 9 | 2023 | 41718 | 0.060 |
Why?
|
| Versicans | 2 | 2021 | 40 | 0.060 |
Why?
|
| Blood Specimen Collection | 1 | 2006 | 238 | 0.060 |
Why?
|
| Growth Inhibitors | 1 | 1986 | 375 | 0.060 |
Why?
|
| Receptors, Leukotriene B4 | 1 | 2005 | 93 | 0.060 |
Why?
|
| Diabetes Mellitus | 7 | 2015 | 5886 | 0.060 |
Why?
|
| Weight Gain | 1 | 2015 | 2360 | 0.060 |
Why?
|
| alpha-Fetoproteins | 1 | 1985 | 229 | 0.060 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2022 | 1197 | 0.060 |
Why?
|
| Liver | 7 | 2001 | 7578 | 0.060 |
Why?
|
| Confidence Intervals | 3 | 2018 | 2920 | 0.060 |
Why?
|
| GTP-Binding Proteins | 2 | 2006 | 946 | 0.060 |
Why?
|
| Peroxisome Proliferators | 2 | 2002 | 6 | 0.060 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2006 | 463 | 0.060 |
Why?
|
| Antirheumatic Agents | 1 | 2014 | 1379 | 0.060 |
Why?
|
| Lysosomes | 4 | 2004 | 937 | 0.060 |
Why?
|
| Fucose | 1 | 2005 | 115 | 0.060 |
Why?
|
| Epithelial Cells | 1 | 2017 | 3698 | 0.060 |
Why?
|
| Alkaline Phosphatase | 2 | 2019 | 861 | 0.060 |
Why?
|
| Granuloma | 1 | 1987 | 329 | 0.060 |
Why?
|
| Stromal Cells | 1 | 2010 | 1335 | 0.060 |
Why?
|
| Trypanosoma cruzi | 2 | 1987 | 204 | 0.060 |
Why?
|
| Extracellular Space | 2 | 1998 | 563 | 0.060 |
Why?
|
| Biopsy, Needle | 2 | 2016 | 1615 | 0.060 |
Why?
|
| Peroxynitrous Acid | 1 | 2024 | 40 | 0.060 |
Why?
|
| Culture Techniques | 2 | 2002 | 529 | 0.060 |
Why?
|
| Cell Nucleus | 6 | 1998 | 2875 | 0.060 |
Why?
|
| Cell Shape | 1 | 2005 | 372 | 0.060 |
Why?
|
| Complement System Proteins | 2 | 1999 | 738 | 0.060 |
Why?
|
| CADASIL | 1 | 2005 | 83 | 0.060 |
Why?
|
| Cricetinae | 5 | 2011 | 2415 | 0.060 |
Why?
|
| Immunoglobulins | 2 | 1999 | 853 | 0.060 |
Why?
|
| Anti-Obesity Agents | 1 | 2008 | 240 | 0.060 |
Why?
|
| Leukotriene B4 | 1 | 2005 | 281 | 0.060 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2005 | 152 | 0.060 |
Why?
|
| Receptors, Interleukin-1 | 2 | 2012 | 260 | 0.060 |
Why?
|
| Transcription Factor AP-1 | 2 | 2004 | 321 | 0.060 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 3431 | 0.060 |
Why?
|
| Research Design | 4 | 2022 | 6210 | 0.060 |
Why?
|
| Biotechnology | 1 | 2006 | 282 | 0.060 |
Why?
|
| Phagocytosis | 1 | 2010 | 1526 | 0.060 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2005 | 168 | 0.060 |
Why?
|
| Eosinophil Granule Proteins | 1 | 2023 | 29 | 0.060 |
Why?
|
| Comorbidity | 2 | 2015 | 10582 | 0.060 |
Why?
|
| Aneurysm | 1 | 2007 | 343 | 0.060 |
Why?
|
| Asthma | 2 | 2016 | 6268 | 0.060 |
Why?
|
| CHO Cells | 4 | 2011 | 1376 | 0.060 |
Why?
|
| Gadolinium DTPA | 1 | 2007 | 823 | 0.060 |
Why?
|
| Heat-Shock Proteins | 1 | 2007 | 792 | 0.060 |
Why?
|
| Tomography | 1 | 2006 | 443 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 2 | 2000 | 6106 | 0.050 |
Why?
|
| Crosses, Genetic | 4 | 2007 | 751 | 0.050 |
Why?
|
| Thromboembolism | 3 | 2009 | 1003 | 0.050 |
Why?
|
| Biological Availability | 1 | 2024 | 387 | 0.050 |
Why?
|
| Cell Separation | 4 | 2009 | 1717 | 0.050 |
Why?
|
| Colonic Neoplasms | 1 | 2015 | 2535 | 0.050 |
Why?
|
| Mineral Oil | 1 | 2023 | 21 | 0.050 |
Why?
|
| Bone Morphogenetic Protein Receptors | 1 | 2023 | 47 | 0.050 |
Why?
|
| Microcirculation | 3 | 2009 | 1282 | 0.050 |
Why?
|
| Necrosis | 6 | 2023 | 1614 | 0.050 |
Why?
|
| Colitis, Ulcerative | 1 | 2015 | 1924 | 0.050 |
Why?
|
| Tropoelastin | 1 | 2003 | 28 | 0.050 |
Why?
|
| Lupus Nephritis | 2 | 2017 | 324 | 0.050 |
Why?
|
| Glucose Intolerance | 1 | 2007 | 579 | 0.050 |
Why?
|
| Phenyl Ethers | 2 | 2002 | 62 | 0.050 |
Why?
|
| Amino Acid Sequence | 4 | 2022 | 13411 | 0.050 |
Why?
|
| Calcium-Binding Proteins | 2 | 2019 | 1081 | 0.050 |
Why?
|
| Muscle Development | 1 | 1985 | 258 | 0.050 |
Why?
|
| Biosensing Techniques | 1 | 2009 | 641 | 0.050 |
Why?
|
| Models, Molecular | 3 | 2022 | 5388 | 0.050 |
Why?
|
| Sleep | 1 | 2019 | 4816 | 0.050 |
Why?
|
| Glycosylation | 2 | 2005 | 1099 | 0.050 |
Why?
|
| United States Food and Drug Administration | 3 | 2020 | 1672 | 0.050 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2023 | 156 | 0.050 |
Why?
|
| Cell Count | 3 | 2019 | 1825 | 0.050 |
Why?
|
| Gadolinium | 1 | 2008 | 964 | 0.050 |
Why?
|
| U937 Cells | 2 | 2000 | 260 | 0.050 |
Why?
|
| Immunity, Active | 1 | 2002 | 58 | 0.050 |
Why?
|
| Chaperonins | 1 | 2002 | 58 | 0.050 |
Why?
|
| Tumor Necrosis Factors | 1 | 2022 | 109 | 0.050 |
Why?
|
| Angiopoietin-1 | 1 | 2003 | 132 | 0.050 |
Why?
|
| Subtilisins | 1 | 2022 | 80 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 2 | 2002 | 911 | 0.050 |
Why?
|
| Anti-Asthmatic Agents | 2 | 2019 | 572 | 0.050 |
Why?
|
| Autoantibodies | 3 | 2010 | 2114 | 0.050 |
Why?
|
| Coronary Restenosis | 1 | 2005 | 396 | 0.050 |
Why?
|
| Thiazoles | 4 | 2003 | 1530 | 0.050 |
Why?
|
| Longitudinal Studies | 4 | 2024 | 14766 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2009 | 2472 | 0.050 |
Why?
|
| Physicians | 1 | 2020 | 4593 | 0.050 |
Why?
|
| Neutropenia | 2 | 2017 | 892 | 0.050 |
Why?
|
| Transplantation Immunology | 3 | 2002 | 537 | 0.050 |
Why?
|
| Prothrombin | 1 | 2022 | 194 | 0.050 |
Why?
|
| Bradycardia | 1 | 2024 | 305 | 0.050 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 2 | 2021 | 299 | 0.050 |
Why?
|
| Preventive Medicine | 1 | 2023 | 246 | 0.050 |
Why?
|
| Cell Communication | 2 | 2001 | 1660 | 0.050 |
Why?
|
| Homocysteine | 2 | 2022 | 637 | 0.050 |
Why?
|
| Scurvy | 1 | 2002 | 36 | 0.050 |
Why?
|
| Lipid Regulating Agents | 1 | 2021 | 21 | 0.050 |
Why?
|
| C-Peptide | 1 | 2004 | 443 | 0.050 |
Why?
|
| Absorbable Implants | 1 | 2024 | 334 | 0.050 |
Why?
|
| Heme Oxygenase-1 | 1 | 2024 | 364 | 0.050 |
Why?
|
| Dose-Response Relationship, Immunologic | 2 | 2000 | 361 | 0.050 |
Why?
|
| Cholinergic Agents | 1 | 2022 | 97 | 0.050 |
Why?
|
| Methylamines | 1 | 2022 | 136 | 0.050 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2022 | 192 | 0.050 |
Why?
|
| Cyclic AMP | 1 | 2006 | 1472 | 0.050 |
Why?
|
| Chlamydia | 2 | 2000 | 33 | 0.050 |
Why?
|
| Molecular Biology | 2 | 1997 | 573 | 0.050 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2005 | 793 | 0.050 |
Why?
|
| Homeostasis | 2 | 2008 | 3345 | 0.050 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 2 | 2015 | 130 | 0.050 |
Why?
|
| Creatinine | 2 | 2022 | 1916 | 0.050 |
Why?
|
| Cycloheximide | 4 | 1987 | 340 | 0.050 |
Why?
|
| Fluorescein-5-isothiocyanate | 2 | 2007 | 220 | 0.050 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2023 | 345 | 0.050 |
Why?
|
| Scattering, Small Angle | 1 | 2021 | 61 | 0.050 |
Why?
|
| 5,8,11,14-Eicosatetraynoic Acid | 1 | 2001 | 9 | 0.050 |
Why?
|
| Muscular Dystrophy, Animal | 2 | 1980 | 89 | 0.050 |
Why?
|
| Calcium Channel Blockers | 1 | 2004 | 688 | 0.050 |
Why?
|
| Cause of Death | 2 | 2024 | 3717 | 0.050 |
Why?
|
| Caspases, Initiator | 1 | 2021 | 31 | 0.050 |
Why?
|
| Polysomnography | 2 | 2018 | 1868 | 0.050 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2003 | 254 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2009 | 3684 | 0.050 |
Why?
|
| rab GTP-Binding Proteins | 2 | 2016 | 247 | 0.050 |
Why?
|
| Electrocardiography | 11 | 2020 | 6409 | 0.050 |
Why?
|
| Regeneration | 1 | 2010 | 1523 | 0.050 |
Why?
|
| Myxoma | 1 | 2001 | 114 | 0.050 |
Why?
|
| Lysophosphatidylcholines | 1 | 2001 | 77 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-sis | 2 | 1998 | 254 | 0.050 |
Why?
|
| Algorithms | 2 | 2019 | 14098 | 0.050 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2015 | 2441 | 0.050 |
Why?
|
| Microscopy, Electron | 3 | 1998 | 2551 | 0.040 |
Why?
|
| X-Ray Diffraction | 1 | 2021 | 416 | 0.040 |
Why?
|
| Receptors, Interleukin | 1 | 2002 | 243 | 0.040 |
Why?
|
| Esters | 1 | 2021 | 212 | 0.040 |
Why?
|
| Rheumatic Heart Disease | 1 | 2022 | 163 | 0.040 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2023 | 382 | 0.040 |
Why?
|
| Organ Specificity | 2 | 2019 | 1966 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2007 | 2457 | 0.040 |
Why?
|
| Philippines | 1 | 2020 | 95 | 0.040 |
Why?
|
| Apolipoproteins A | 2 | 2014 | 95 | 0.040 |
Why?
|
| Reference Values | 4 | 2007 | 4918 | 0.040 |
Why?
|
| Genomics | 2 | 2007 | 5924 | 0.040 |
Why?
|
| Copper Radioisotopes | 2 | 2013 | 99 | 0.040 |
Why?
|
| Platelet Adhesiveness | 1 | 2000 | 154 | 0.040 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 2 | 2006 | 897 | 0.040 |
Why?
|
| Arteriosclerosis Obliterans | 1 | 1999 | 8 | 0.040 |
Why?
|
| Postoperative Period | 2 | 2015 | 1824 | 0.040 |
Why?
|
| Phosphate-Binding Proteins | 1 | 2021 | 93 | 0.040 |
Why?
|
| Tryptophan | 1 | 2002 | 484 | 0.040 |
Why?
|
| Transcription Factor RelA | 2 | 2001 | 252 | 0.040 |
Why?
|
| Bile Acids and Salts | 1 | 2022 | 398 | 0.040 |
Why?
|
| Stress, Psychological | 2 | 2014 | 4526 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2002 | 482 | 0.040 |
Why?
|
| Peptides | 2 | 2009 | 4348 | 0.040 |
Why?
|
| Sulfhydryl Compounds | 1 | 2021 | 296 | 0.040 |
Why?
|
| Polyisoprenyl Phosphates | 1 | 2000 | 38 | 0.040 |
Why?
|
| Cholates | 1 | 1999 | 4 | 0.040 |
Why?
|
| Thoracic Diseases | 1 | 1981 | 99 | 0.040 |
Why?
|
| Galactosamine | 1 | 2019 | 26 | 0.040 |
Why?
|
| Diphtheria Toxin | 1 | 2020 | 253 | 0.040 |
Why?
|
| Medicine, Chinese Traditional | 1 | 2020 | 75 | 0.040 |
Why?
|
| Rhodamines | 1 | 2020 | 179 | 0.040 |
Why?
|
| Dogs | 11 | 1989 | 3834 | 0.040 |
Why?
|
| Immune Sera | 3 | 2000 | 605 | 0.040 |
Why?
|
| Hemorheology | 1 | 2020 | 144 | 0.040 |
Why?
|
| Hot Temperature | 3 | 2019 | 1441 | 0.040 |
Why?
|
| Molsidomine | 2 | 1996 | 22 | 0.040 |
Why?
|
| Factor X | 1 | 1999 | 64 | 0.040 |
Why?
|
| Matrix Metalloproteinases, Membrane-Associated | 1 | 1999 | 13 | 0.040 |
Why?
|
| Genes, myb | 1 | 2019 | 18 | 0.040 |
Why?
|
| Chemokines, CC | 1 | 2000 | 286 | 0.040 |
Why?
|
| Cells | 1 | 2001 | 162 | 0.040 |
Why?
|
| Cyclooxygenase 1 | 1 | 1999 | 98 | 0.040 |
Why?
|
| Matrix Metalloproteinase 11 | 1 | 1999 | 15 | 0.040 |
Why?
|
| Acetates | 5 | 1976 | 314 | 0.040 |
Why?
|
| beta-N-Acetylhexosaminidases | 1 | 2019 | 43 | 0.040 |
Why?
|
| Arginase | 1 | 2019 | 81 | 0.040 |
Why?
|
| Colombia | 1 | 2020 | 287 | 0.040 |
Why?
|
| Advisory Committees | 1 | 2023 | 797 | 0.040 |
Why?
|
| Postmortem Changes | 1 | 1999 | 119 | 0.040 |
Why?
|
| Immediate-Early Proteins | 1 | 2002 | 444 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2002 | 3797 | 0.040 |
Why?
|
| Periodontics | 2 | 2009 | 45 | 0.040 |
Why?
|
| Terrorism | 1 | 2002 | 211 | 0.040 |
Why?
|
| COS Cells | 2 | 2015 | 1135 | 0.040 |
Why?
|
| Nitroprusside | 2 | 1996 | 271 | 0.040 |
Why?
|
| Aptamers, Peptide | 1 | 2018 | 28 | 0.040 |
Why?
|
| Acids | 1 | 2019 | 125 | 0.040 |
Why?
|
| Polymyxin B | 2 | 1989 | 44 | 0.040 |
Why?
|
| Streptozocin | 1 | 2019 | 189 | 0.040 |
Why?
|
| Prostaglandin D2 | 4 | 2000 | 108 | 0.040 |
Why?
|
| Sesquiterpenes | 1 | 2000 | 175 | 0.040 |
Why?
|
| Retrospective Studies | 6 | 2024 | 81659 | 0.040 |
Why?
|
| Amides | 1 | 2021 | 451 | 0.040 |
Why?
|
| Regional Blood Flow | 3 | 2014 | 1479 | 0.040 |
Why?
|
| Factor VIIa | 1 | 1999 | 103 | 0.040 |
Why?
|
| Muscle Cells | 1 | 2019 | 194 | 0.040 |
Why?
|
| Isomerism | 1 | 1998 | 197 | 0.040 |
Why?
|
| Integrin beta Chains | 1 | 2019 | 115 | 0.040 |
Why?
|
| Acetylation | 4 | 2011 | 1055 | 0.040 |
Why?
|
| Guidelines as Topic | 1 | 2005 | 1396 | 0.040 |
Why?
|
| Estradiol | 3 | 1972 | 1951 | 0.040 |
Why?
|
| Models, Chemical | 1 | 2000 | 607 | 0.040 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2003 | 1567 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2022 | 1044 | 0.040 |
Why?
|
| Pyrazoles | 1 | 2009 | 2028 | 0.040 |
Why?
|
| Helicobacter pylori | 1 | 2002 | 380 | 0.040 |
Why?
|
| Isotretinoin | 1 | 2019 | 135 | 0.040 |
Why?
|
| Brain Infarction | 1 | 2020 | 285 | 0.040 |
Why?
|
| Hypothalamic Area, Lateral | 1 | 2019 | 108 | 0.040 |
Why?
|
| Ferritins | 1 | 2021 | 601 | 0.040 |
Why?
|
| Amino Acids | 2 | 1984 | 1712 | 0.040 |
Why?
|
| Fibromuscular Dysplasia | 1 | 1998 | 55 | 0.040 |
Why?
|
| Helicobacter Infections | 1 | 2002 | 390 | 0.040 |
Why?
|
| Gelsolin | 1 | 1998 | 189 | 0.040 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2022 | 827 | 0.040 |
Why?
|
| Receptors, Leptin | 1 | 2019 | 352 | 0.040 |
Why?
|
| Heart Neoplasms | 1 | 2001 | 374 | 0.040 |
Why?
|
| Genetic Variation | 1 | 2013 | 6611 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2010 | 8940 | 0.040 |
Why?
|
| Transaminases | 1 | 2018 | 198 | 0.040 |
Why?
|
| Morpholines | 2 | 2016 | 584 | 0.040 |
Why?
|
| Dietary Fats, Unsaturated | 2 | 2015 | 222 | 0.040 |
Why?
|
| Biopsy | 2 | 2021 | 6777 | 0.040 |
Why?
|
| Interleukin-2 | 4 | 2002 | 1894 | 0.040 |
Why?
|
| Hypertension, Pulmonary | 1 | 2009 | 1604 | 0.040 |
Why?
|
| Cytokine Receptor Common beta Subunit | 1 | 2017 | 22 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2016 | 1331 | 0.040 |
Why?
|
| Interleukin-23 | 1 | 2019 | 202 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 1 | 1999 | 610 | 0.040 |
Why?
|
| Mice, Inbred C3H | 3 | 2009 | 915 | 0.040 |
Why?
|
| Proteoglycans | 1 | 2001 | 807 | 0.040 |
Why?
|
| Cadaver | 2 | 2017 | 1362 | 0.040 |
Why?
|
| Mortality | 3 | 2018 | 2909 | 0.040 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2022 | 878 | 0.040 |
Why?
|
| Enterocytes | 1 | 2019 | 220 | 0.040 |
Why?
|
| Gelatin | 2 | 1998 | 227 | 0.040 |
Why?
|
| Osteopetrosis | 1 | 1997 | 42 | 0.040 |
Why?
|
| Endosonography | 2 | 2013 | 626 | 0.040 |
Why?
|
| Histamine | 1 | 2019 | 496 | 0.040 |
Why?
|
| Herpesviridae | 1 | 1997 | 104 | 0.040 |
Why?
|
| Carotid Artery, Internal | 1 | 2020 | 440 | 0.040 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2017 | 113 | 0.040 |
Why?
|
| Macrophages, Alveolar | 1 | 2019 | 413 | 0.030 |
Why?
|
| Peritonitis | 2 | 2011 | 368 | 0.030 |
Why?
|
| Insulin | 6 | 2022 | 6602 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2024 | 2120 | 0.030 |
Why?
|
| Peptidyl-Dipeptidase A | 2 | 2014 | 325 | 0.030 |
Why?
|
| Taiwan | 1 | 2018 | 521 | 0.030 |
Why?
|
| Review Literature as Topic | 1 | 2018 | 297 | 0.030 |
Why?
|
| Antigens, CD1 | 1 | 1999 | 434 | 0.030 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 1996 | 68 | 0.030 |
Why?
|
| Chemokine CXCL12 | 2 | 2014 | 457 | 0.030 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2017 | 158 | 0.030 |
Why?
|
| Adipose Tissue, Brown | 1 | 2022 | 776 | 0.030 |
Why?
|
| Tretinoin | 1 | 2019 | 524 | 0.030 |
Why?
|
| Sialoglycoproteins | 1 | 1997 | 316 | 0.030 |
Why?
|
| Binding Sites | 4 | 2018 | 6014 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2004 | 2093 | 0.030 |
Why?
|
| Uterus | 2 | 1972 | 661 | 0.030 |
Why?
|
| Parabiosis | 1 | 2016 | 65 | 0.030 |
Why?
|
| Ventricular Function, Left | 2 | 2023 | 3934 | 0.030 |
Why?
|
| Acridine Orange | 1 | 1996 | 28 | 0.030 |
Why?
|
| Ethidium | 1 | 1996 | 27 | 0.030 |
Why?
|
| Connexin 43 | 1 | 2017 | 202 | 0.030 |
Why?
|
| Staining and Labeling | 3 | 2009 | 1076 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 13650 | 0.030 |
Why?
|
| Receptors, Thrombin | 1 | 1996 | 130 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2017 | 287 | 0.030 |
Why?
|
| Casein Kinase I | 1 | 2016 | 46 | 0.030 |
Why?
|
| Sex Factors | 3 | 2018 | 10622 | 0.030 |
Why?
|
| Calcium Chloride | 1 | 2015 | 78 | 0.030 |
Why?
|
| Japan | 1 | 2020 | 1418 | 0.030 |
Why?
|
| Pharmaceutical Vehicles | 1 | 1995 | 56 | 0.030 |
Why?
|
| Chemokine CX3CL1 | 1 | 2015 | 62 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 2005 | 1705 | 0.030 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2017 | 169 | 0.030 |
Why?
|
| Isoprostanes | 1 | 2015 | 21 | 0.030 |
Why?
|
| F2-Isoprostanes | 1 | 2015 | 35 | 0.030 |
Why?
|
| Casein Kinase II | 1 | 2016 | 121 | 0.030 |
Why?
|
| Metabolome | 1 | 2022 | 1008 | 0.030 |
Why?
|
| Rats, Wistar | 3 | 2009 | 1885 | 0.030 |
Why?
|
| Intention to Treat Analysis | 1 | 2016 | 418 | 0.030 |
Why?
|
| Osmolar Concentration | 1 | 1996 | 654 | 0.030 |
Why?
|
| RANK Ligand | 1 | 2017 | 321 | 0.030 |
Why?
|
| Troponin T | 1 | 2020 | 786 | 0.030 |
Why?
|
| Cerebrovascular Disorders | 1 | 2002 | 1478 | 0.030 |
Why?
|
| Physician's Role | 1 | 2002 | 923 | 0.030 |
Why?
|
| Dideoxynucleosides | 1 | 2015 | 135 | 0.030 |
Why?
|
| GPI-Linked Proteins | 1 | 2016 | 472 | 0.030 |
Why?
|
| Receptors, Angiotensin | 2 | 2009 | 141 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 1995 | 416 | 0.030 |
Why?
|
| Caseins | 1 | 1995 | 105 | 0.030 |
Why?
|
| Chemokine CCL3 | 1 | 2014 | 85 | 0.030 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 2015 | 94 | 0.030 |
Why?
|
| Complement C3 | 1 | 2017 | 434 | 0.030 |
Why?
|
| Chagas Disease | 2 | 1987 | 166 | 0.030 |
Why?
|
| Kidney Tubules | 1 | 2017 | 454 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 4 | 2020 | 7469 | 0.030 |
Why?
|
| Stem Cell Transplantation | 1 | 2003 | 1596 | 0.030 |
Why?
|
| Budesonide | 1 | 2016 | 162 | 0.030 |
Why?
|
| Glomerulonephritis | 1 | 2017 | 333 | 0.030 |
Why?
|
| HLA-D Antigens | 1 | 1995 | 130 | 0.030 |
Why?
|
| Carrier Proteins | 2 | 2019 | 4925 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2001 | 1729 | 0.030 |
Why?
|
| Shock, Septic | 1 | 2001 | 772 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2010 | 8108 | 0.030 |
Why?
|
| Pyrrolidinones | 1 | 2014 | 116 | 0.030 |
Why?
|
| Angina Pectoris | 2 | 2011 | 956 | 0.030 |
Why?
|
| Hyaluronoglucosaminidase | 4 | 1977 | 138 | 0.030 |
Why?
|
| Bacterial Proteins | 2 | 2010 | 3834 | 0.030 |
Why?
|
| Serotonin | 1 | 2019 | 1045 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2004 | 2856 | 0.030 |
Why?
|
| Fibroblast Growth Factor 5 | 1 | 1993 | 9 | 0.030 |
Why?
|
| Vasomotor System | 1 | 1995 | 208 | 0.030 |
Why?
|
| Radiography, Thoracic | 1 | 1981 | 1320 | 0.030 |
Why?
|
| Ischemic Preconditioning, Myocardial | 1 | 2014 | 69 | 0.030 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 4 | 1 | 1993 | 18 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2016 | 1377 | 0.030 |
Why?
|
| Citrulline | 1 | 2014 | 107 | 0.030 |
Why?
|
| Escherichia coli | 1 | 1986 | 4209 | 0.030 |
Why?
|
| Fibroblast Growth Factor 10 | 1 | 1993 | 31 | 0.030 |
Why?
|
| Chick Embryo | 3 | 1999 | 973 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2017 | 2843 | 0.030 |
Why?
|
| Thiocarbamates | 2 | 2006 | 30 | 0.030 |
Why?
|
| Echocardiography | 5 | 2009 | 5042 | 0.030 |
Why?
|
| Blotting, Southern | 1 | 1994 | 775 | 0.030 |
Why?
|
| Observer Variation | 2 | 2016 | 2616 | 0.030 |
Why?
|
| Fibroblast Growth Factor 7 | 1 | 1993 | 59 | 0.030 |
Why?
|
| Mesenteric Arteries | 1 | 2014 | 177 | 0.030 |
Why?
|
| Cytoskeleton | 1 | 1998 | 1178 | 0.030 |
Why?
|
| Sepsis | 2 | 2018 | 2605 | 0.030 |
Why?
|
| Denmark | 1 | 2016 | 776 | 0.030 |
Why?
|
| Amino Alcohols | 1 | 1973 | 19 | 0.030 |
Why?
|
| Cross-Sectional Studies | 4 | 2022 | 26325 | 0.030 |
Why?
|
| Endometrium | 1 | 1976 | 406 | 0.030 |
Why?
|
| Antimalarials | 1 | 2020 | 909 | 0.030 |
Why?
|
| Intracellular Membranes | 1 | 1994 | 386 | 0.030 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2015 | 199 | 0.030 |
Why?
|
| Health Services Needs and Demand | 1 | 2021 | 1405 | 0.030 |
Why?
|
| Federal Government | 1 | 2015 | 266 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2019 | 922 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2005 | 8535 | 0.030 |
Why?
|
| Mitral Valve | 1 | 2001 | 1475 | 0.030 |
Why?
|
| Autophagy | 1 | 2021 | 1347 | 0.030 |
Why?
|
| Keratinocytes | 1 | 1997 | 876 | 0.030 |
Why?
|
| Peer Review, Research | 1 | 1996 | 343 | 0.030 |
Why?
|
| Cytosol | 1 | 1976 | 885 | 0.030 |
Why?
|
| Protein Kinases | 1 | 2020 | 1610 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2014 | 685 | 0.030 |
Why?
|
| Mitochondria, Heart | 1 | 2014 | 229 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 13491 | 0.030 |
Why?
|
| Action Potentials | 1 | 2020 | 1835 | 0.030 |
Why?
|
| Cell Size | 2 | 2009 | 624 | 0.030 |
Why?
|
| Genetic Vectors | 3 | 1998 | 3402 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2013 | 6215 | 0.030 |
Why?
|
| Iron | 1 | 2021 | 1811 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2016 | 1882 | 0.030 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 1993 | 259 | 0.030 |
Why?
|
| Neopterin | 1 | 2012 | 58 | 0.030 |
Why?
|
| Interferons | 2 | 2002 | 716 | 0.020 |
Why?
|
| Renal Artery | 1 | 2014 | 355 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2015 | 1181 | 0.020 |
Why?
|
| Bronchodilator Agents | 1 | 2016 | 513 | 0.020 |
Why?
|
| Zirconium | 1 | 2013 | 109 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 1994 | 354 | 0.020 |
Why?
|
| Prediabetic State | 1 | 2018 | 547 | 0.020 |
Why?
|
| Chromosomes | 1 | 1975 | 578 | 0.020 |
Why?
|
| Eating | 1 | 2019 | 1541 | 0.020 |
Why?
|
| Sleep Deprivation | 1 | 2019 | 848 | 0.020 |
Why?
|
| Membrane Lipids | 1 | 2013 | 241 | 0.020 |
Why?
|
| Aminopyridines | 1 | 2016 | 578 | 0.020 |
Why?
|
| Nucleosomes | 1 | 1996 | 492 | 0.020 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2001 | 1414 | 0.020 |
Why?
|
| Phosphatidylserines | 1 | 2013 | 186 | 0.020 |
Why?
|
| Bleeding Time | 1 | 2011 | 83 | 0.020 |
Why?
|
| Phosphorus | 1 | 2013 | 336 | 0.020 |
Why?
|
| Precipitin Tests | 2 | 1989 | 816 | 0.020 |
Why?
|
| Durapatite | 1 | 2013 | 167 | 0.020 |
Why?
|
| Proteome | 1 | 2022 | 1890 | 0.020 |
Why?
|
| Chemical Fractionation | 2 | 1995 | 60 | 0.020 |
Why?
|
| Immunoconjugates | 1 | 1999 | 975 | 0.020 |
Why?
|
| Antigens | 2 | 2010 | 1442 | 0.020 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2020 | 1749 | 0.020 |
Why?
|
| Leukocyte L1 Antigen Complex | 1 | 2011 | 93 | 0.020 |
Why?
|
| Adenoviridae | 1 | 1995 | 1092 | 0.020 |
Why?
|
| Adrenalectomy | 2 | 1973 | 347 | 0.020 |
Why?
|
| Immune Tolerance | 1 | 2000 | 2322 | 0.020 |
Why?
|
| Rhodobacter capsulatus | 1 | 1990 | 11 | 0.020 |
Why?
|
| STAT1 Transcription Factor | 1 | 2012 | 341 | 0.020 |
Why?
|
| Binding, Competitive | 2 | 2009 | 1141 | 0.020 |
Why?
|
| Radioisotopes | 1 | 2013 | 509 | 0.020 |
Why?
|
| Particulate Matter | 1 | 2023 | 2621 | 0.020 |
Why?
|
| Hydrocortisone | 3 | 1974 | 1840 | 0.020 |
Why?
|
| Plant Oils | 1 | 1992 | 199 | 0.020 |
Why?
|
| Women's Health | 1 | 2020 | 2082 | 0.020 |
Why?
|
| Smoking | 4 | 2017 | 9081 | 0.020 |
Why?
|
| Heart Atria | 1 | 2017 | 1362 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2016 | 969 | 0.020 |
Why?
|
| Surface Plasmon Resonance | 1 | 2011 | 268 | 0.020 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 1992 | 239 | 0.020 |
Why?
|
| Receptors, Cytokine | 1 | 2011 | 258 | 0.020 |
Why?
|
| Government Regulation | 1 | 2015 | 525 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1992 | 1305 | 0.020 |
Why?
|
| Histocompatibility | 1 | 2011 | 322 | 0.020 |
Why?
|
| Disease-Free Survival | 2 | 2013 | 6844 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 1995 | 1207 | 0.020 |
Why?
|
| Malondialdehyde | 1 | 2010 | 113 | 0.020 |
Why?
|
| Halogenated Diphenyl Ethers | 2 | 2002 | 84 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 1991 | 861 | 0.020 |
Why?
|
| Fenofibrate | 2 | 2002 | 87 | 0.020 |
Why?
|
| Thiophenes | 1 | 2014 | 570 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 2 | 2003 | 258 | 0.020 |
Why?
|
| Lectins, C-Type | 2 | 2006 | 591 | 0.020 |
Why?
|
| Protein Transport | 1 | 2016 | 1944 | 0.020 |
Why?
|
| Immunoglobulin Isotypes | 1 | 2010 | 158 | 0.020 |
Why?
|
| Propensity Score | 1 | 2018 | 1971 | 0.020 |
Why?
|
| Feasibility Studies | 2 | 2013 | 5311 | 0.020 |
Why?
|
| Creatine Kinase | 5 | 1975 | 683 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2023 | 3591 | 0.020 |
Why?
|
| Spermidine | 1 | 1989 | 63 | 0.020 |
Why?
|
| Pregnenolone | 1 | 1969 | 27 | 0.020 |
Why?
|
| Sulfuric Acids | 1 | 1969 | 36 | 0.020 |
Why?
|
| Computational Biology | 1 | 2022 | 3567 | 0.020 |
Why?
|
| Kidney | 2 | 2017 | 7063 | 0.020 |
Why?
|
| Hypersensitivity, Delayed | 1 | 1991 | 491 | 0.020 |
Why?
|
| Killer Cells, Natural | 2 | 1989 | 2209 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2011 | 3738 | 0.020 |
Why?
|
| Amidohydrolases | 1 | 1970 | 160 | 0.020 |
Why?
|
| Thrombocytopenia | 1 | 2017 | 1172 | 0.020 |
Why?
|
| Vascular Resistance | 1 | 1992 | 939 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2023 | 5618 | 0.020 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1989 | 341 | 0.020 |
Why?
|
| Muscle Denervation | 2 | 1980 | 60 | 0.020 |
Why?
|
| Peptides, Cyclic | 1 | 2011 | 390 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 2538 | 0.020 |
Why?
|
| Vaccines | 1 | 2018 | 842 | 0.020 |
Why?
|
| Adolescent | 5 | 2023 | 89046 | 0.020 |
Why?
|
| E-Box Elements | 1 | 2009 | 21 | 0.020 |
Why?
|
| Ferrosoferric Oxide | 1 | 2010 | 348 | 0.020 |
Why?
|
| Antigens, Differentiation | 3 | 1999 | 920 | 0.020 |
Why?
|
| Triazoles | 1 | 2014 | 903 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2018 | 1466 | 0.020 |
Why?
|
| 2',5'-Oligoadenylate Synthetase | 1 | 1989 | 27 | 0.020 |
Why?
|
| Iopamidol | 1 | 2009 | 188 | 0.020 |
Why?
|
| Australia | 1 | 2013 | 1263 | 0.020 |
Why?
|
| Lipid A | 1 | 1989 | 70 | 0.020 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2009 | 79 | 0.020 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2009 | 56 | 0.020 |
Why?
|
| Liver Transplantation | 1 | 2001 | 2416 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2014 | 1188 | 0.020 |
Why?
|
| Genotype | 2 | 2020 | 13035 | 0.020 |
Why?
|
| Body Mass Index | 3 | 2016 | 13048 | 0.020 |
Why?
|
| Tetrazoles | 1 | 2014 | 923 | 0.020 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 1989 | 187 | 0.020 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 1989 | 1352 | 0.020 |
Why?
|
| Propranolol | 4 | 1974 | 493 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2015 | 2721 | 0.020 |
Why?
|
| Lung Compliance | 1 | 2009 | 207 | 0.020 |
Why?
|
| Upper Extremity | 1 | 2014 | 684 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2010 | 287 | 0.020 |
Why?
|
| Cathepsin B | 1 | 2008 | 80 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2018 | 2698 | 0.020 |
Why?
|
| Temperature | 1 | 1995 | 2232 | 0.020 |
Why?
|
| Peptide Library | 1 | 2010 | 351 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2017 | 10092 | 0.020 |
Why?
|
| Biomedical Engineering | 1 | 2010 | 284 | 0.020 |
Why?
|
| Half-Life | 1 | 2009 | 648 | 0.020 |
Why?
|
| Pulmonary Eosinophilia | 1 | 2009 | 78 | 0.020 |
Why?
|
| Estrone | 1 | 1969 | 234 | 0.020 |
Why?
|
| Aldosterone | 1 | 1973 | 881 | 0.020 |
Why?
|
| Oxyquinoline | 1 | 2008 | 17 | 0.020 |
Why?
|
| Perioperative Care | 1 | 2016 | 1043 | 0.020 |
Why?
|
| S100 Proteins | 1 | 2009 | 216 | 0.020 |
Why?
|
| Dehydroepiandrosterone | 1 | 1969 | 259 | 0.020 |
Why?
|
| Phosphatidylinositols | 1 | 1989 | 280 | 0.020 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2015 | 1092 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2020 | 3700 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2011 | 621 | 0.020 |
Why?
|
| Splenectomy | 1 | 2009 | 390 | 0.020 |
Why?
|
| Airway Resistance | 1 | 2009 | 407 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 1999 | 3212 | 0.020 |
Why?
|
| Tritium | 3 | 1973 | 707 | 0.020 |
Why?
|
| Luciferases | 2 | 2000 | 713 | 0.020 |
Why?
|
| Wounds and Injuries | 1 | 1980 | 2513 | 0.020 |
Why?
|
| Hypoglycemia | 1 | 1975 | 896 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2015 | 1626 | 0.020 |
Why?
|
| beta-Galactosidase | 2 | 2001 | 573 | 0.020 |
Why?
|
| Isoelectric Point | 1 | 1987 | 76 | 0.020 |
Why?
|
| Cardiac Volume | 2 | 2002 | 197 | 0.020 |
Why?
|
| Antigens, Surface | 2 | 1989 | 1617 | 0.020 |
Why?
|
| Ferric Compounds | 1 | 2009 | 376 | 0.020 |
Why?
|
| Chagas Cardiomyopathy | 1 | 1987 | 72 | 0.020 |
Why?
|
| Coloring Agents | 2 | 2001 | 565 | 0.020 |
Why?
|
| South Africa | 1 | 2013 | 1873 | 0.020 |
Why?
|
| Norbornanes | 1 | 2006 | 10 | 0.020 |
Why?
|
| Phosphatidylinositol Diacylglycerol-Lyase | 1 | 2006 | 20 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1973 | 1243 | 0.020 |
Why?
|
| Epoxy Compounds | 1 | 2007 | 137 | 0.020 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2009 | 425 | 0.020 |
Why?
|
| Thiones | 1 | 2006 | 50 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2009 | 694 | 0.020 |
Why?
|
| Endocytosis | 1 | 2011 | 951 | 0.020 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 1 | 2009 | 257 | 0.020 |
Why?
|
| Isoproterenol | 4 | 1974 | 398 | 0.020 |
Why?
|
| Thymus Gland | 1 | 1992 | 1264 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2024 | 7435 | 0.020 |
Why?
|
| Connective Tissue | 1 | 2009 | 425 | 0.020 |
Why?
|
| Human Genome Project | 1 | 2007 | 202 | 0.020 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2011 | 748 | 0.020 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2017 | 1564 | 0.020 |
Why?
|
| Citric Acid | 1 | 2006 | 124 | 0.020 |
Why?
|
| Matrix Metalloproteinase 10 | 1 | 2006 | 11 | 0.020 |
Why?
|
| Cell Wall | 1 | 1989 | 419 | 0.020 |
Why?
|
| Mesoderm | 1 | 1989 | 679 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2016 | 2163 | 0.020 |
Why?
|
| Ovum | 1 | 1987 | 187 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2020 | 3928 | 0.020 |
Why?
|
| Antibody Formation | 1 | 1991 | 1392 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 4780 | 0.020 |
Why?
|
| Edetic Acid | 1 | 2006 | 277 | 0.020 |
Why?
|
| Delayed-Action Preparations | 1 | 2010 | 965 | 0.020 |
Why?
|
| Immunization | 1 | 2010 | 1218 | 0.020 |
Why?
|
| Survival Rate | 3 | 2007 | 12823 | 0.020 |
Why?
|
| Schistosoma mansoni | 1 | 1987 | 156 | 0.020 |
Why?
|
| alpha-Macroglobulins | 1 | 1985 | 60 | 0.020 |
Why?
|
| Butylated Hydroxytoluene | 1 | 1985 | 8 | 0.020 |
Why?
|
| Blood Preservation | 1 | 2006 | 169 | 0.020 |
Why?
|
| Rheology | 1 | 2007 | 346 | 0.020 |
Why?
|
| S-Nitrosoglutathione | 2 | 1995 | 23 | 0.020 |
Why?
|
| Ligation | 4 | 2002 | 446 | 0.020 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2006 | 213 | 0.020 |
Why?
|
| Nitroso Compounds | 2 | 1995 | 70 | 0.020 |
Why?
|
| Umbilical Veins | 1 | 2006 | 423 | 0.020 |
Why?
|
| Serum | 1 | 2006 | 206 | 0.020 |
Why?
|
| Genes, Reporter | 2 | 2000 | 1526 | 0.020 |
Why?
|
| Phosphates | 1 | 2009 | 765 | 0.020 |
Why?
|
| Thymidine | 1 | 1985 | 297 | 0.020 |
Why?
|
| Glycolysis | 3 | 1981 | 836 | 0.020 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 1986 | 174 | 0.020 |
Why?
|
| China | 1 | 2011 | 2394 | 0.020 |
Why?
|
| Cricetulus | 1 | 2007 | 810 | 0.020 |
Why?
|
| Child | 2 | 2023 | 80771 | 0.020 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2007 | 384 | 0.010 |
Why?
|
| Models, Anatomic | 1 | 2008 | 679 | 0.010 |
Why?
|
| Bilirubin | 1 | 2006 | 440 | 0.010 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2006 | 234 | 0.010 |
Why?
|
| Photosensitizing Agents | 1 | 2009 | 627 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2011 | 3760 | 0.010 |
Why?
|
| Drug Contamination | 1 | 1985 | 151 | 0.010 |
Why?
|
| Pyrrolidines | 2 | 1999 | 339 | 0.010 |
Why?
|
| Obesity, Morbid | 1 | 2015 | 1293 | 0.010 |
Why?
|
| Muscular Diseases | 1 | 2008 | 552 | 0.010 |
Why?
|
| Medication Adherence | 1 | 2016 | 2191 | 0.010 |
Why?
|
| Organometallic Compounds | 1 | 2008 | 648 | 0.010 |
Why?
|
| Endovascular Procedures | 1 | 2018 | 2215 | 0.010 |
Why?
|
| Graft vs Host Disease | 1 | 2017 | 3049 | 0.010 |
Why?
|
| Papio | 1 | 1986 | 672 | 0.010 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2004 | 105 | 0.010 |
Why?
|
| Organoids | 2 | 1981 | 740 | 0.010 |
Why?
|
| Canada | 1 | 2009 | 2127 | 0.010 |
Why?
|
| Cardiotonic Agents | 1 | 2007 | 540 | 0.010 |
Why?
|
| Chromones | 1 | 2004 | 148 | 0.010 |
Why?
|
| Nephrectomy | 1 | 2009 | 928 | 0.010 |
Why?
|
| Graft Enhancement, Immunologic | 1 | 2003 | 58 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2011 | 3948 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 8628 | 0.010 |
Why?
|
| Acute-Phase Proteins | 1 | 2004 | 251 | 0.010 |
Why?
|
| Assisted Circulation | 2 | 1974 | 99 | 0.010 |
Why?
|
| Dimerization | 1 | 2005 | 882 | 0.010 |
Why?
|
| Quality of Life | 2 | 2021 | 13485 | 0.010 |
Why?
|
| Receptor, Insulin | 1 | 2007 | 839 | 0.010 |
Why?
|
| Plasma | 1 | 2006 | 583 | 0.010 |
Why?
|
| Body Weight | 2 | 2007 | 4627 | 0.010 |
Why?
|
| Microarray Analysis | 1 | 2006 | 751 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2022 | 12790 | 0.010 |
Why?
|
| Dactinomycin | 2 | 1973 | 304 | 0.010 |
Why?
|
| Oncogenes | 1 | 1988 | 1232 | 0.010 |
Why?
|
| Transferrin | 1 | 1984 | 283 | 0.010 |
Why?
|
| Glutathione | 2 | 1995 | 589 | 0.010 |
Why?
|
| Freund's Adjuvant | 1 | 2002 | 144 | 0.010 |
Why?
|
| Microscopy | 1 | 2007 | 903 | 0.010 |
Why?
|
| Light | 1 | 2008 | 1358 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2011 | 2575 | 0.010 |
Why?
|
| Public Health Practice | 1 | 2004 | 220 | 0.010 |
Why?
|
| Paclitaxel | 1 | 2010 | 1728 | 0.010 |
Why?
|
| Testosterone | 2 | 1972 | 2490 | 0.010 |
Why?
|
| Interleukin-18 Receptor alpha Subunit | 1 | 2002 | 18 | 0.010 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2013 | 2144 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2008 | 2063 | 0.010 |
Why?
|
| Probability | 1 | 2007 | 2476 | 0.010 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2002 | 133 | 0.010 |
Why?
|
| Androstadienes | 1 | 2004 | 348 | 0.010 |
Why?
|
| Philosophy, Medical | 1 | 2002 | 78 | 0.010 |
Why?
|
| Diagnosis, Differential | 2 | 2009 | 12986 | 0.010 |
Why?
|
| Megakaryocytes | 1 | 2006 | 557 | 0.010 |
Why?
|
| Spain | 1 | 2003 | 483 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2006 | 1206 | 0.010 |
Why?
|
| Hospitalization | 2 | 2013 | 10815 | 0.010 |
Why?
|
| Drug Synergism | 1 | 1985 | 1759 | 0.010 |
Why?
|
| Interferon-Stimulated Gene Factor 3 | 1 | 2001 | 10 | 0.010 |
Why?
|
| Chromatography, Agarose | 1 | 2001 | 29 | 0.010 |
Why?
|
| Biglycan | 1 | 2001 | 10 | 0.010 |
Why?
|
| Scavenger Receptors, Class A | 1 | 2001 | 52 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2003 | 347 | 0.010 |
Why?
|
| Decorin | 1 | 2001 | 38 | 0.010 |
Why?
|
| Seroepidemiologic Studies | 1 | 2002 | 404 | 0.010 |
Why?
|
| Apolipoproteins | 1 | 2003 | 328 | 0.010 |
Why?
|
| Pregnancy | 1 | 2023 | 30238 | 0.010 |
Why?
|
| Logistic Models | 1 | 2016 | 13284 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-rel | 1 | 2001 | 71 | 0.010 |
Why?
|
| Receptors, CCR3 | 1 | 2000 | 62 | 0.010 |
Why?
|
| Sarcolemma | 1 | 1981 | 66 | 0.010 |
Why?
|
| Methylhistidines | 1 | 1980 | 35 | 0.010 |
Why?
|
| Research | 2 | 2000 | 1977 | 0.010 |
Why?
|
| Selenium | 1 | 1984 | 418 | 0.010 |
Why?
|
| Mycobacterium | 1 | 2002 | 252 | 0.010 |
Why?
|
| Horseradish Peroxidase | 1 | 1981 | 169 | 0.010 |
Why?
|
| Chemokine CCL11 | 1 | 2000 | 128 | 0.010 |
Why?
|
| Hyperinsulinism | 1 | 2004 | 402 | 0.010 |
Why?
|
| Azo Compounds | 1 | 2001 | 116 | 0.010 |
Why?
|
| Thrombophilia | 1 | 2003 | 308 | 0.010 |
Why?
|
| Administration, Intranasal | 1 | 2002 | 483 | 0.010 |
Why?
|
| Microbodies | 1 | 2000 | 34 | 0.010 |
Why?
|
| Chondroitin Sulfates | 1 | 2001 | 174 | 0.010 |
Why?
|
| Iodoacetates | 1 | 1980 | 17 | 0.010 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2001 | 142 | 0.010 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2001 | 153 | 0.010 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 2001 | 111 | 0.010 |
Why?
|
| p-Methoxy-N-methylphenethylamine | 1 | 1980 | 41 | 0.010 |
Why?
|
| Antipain | 1 | 1980 | 2 | 0.010 |
Why?
|
| Dithiothreitol | 1 | 1980 | 94 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 2002 | 1062 | 0.010 |
Why?
|
| Kidney Transplantation | 1 | 1995 | 4268 | 0.010 |
Why?
|
| Drug Monitoring | 1 | 2006 | 963 | 0.010 |
Why?
|
| Receptors, Notch | 1 | 2005 | 751 | 0.010 |
Why?
|
| Myofibrils | 1 | 1981 | 143 | 0.010 |
Why?
|
| Bungarotoxins | 1 | 1980 | 47 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2016 | 8068 | 0.010 |
Why?
|
| Starvation | 1 | 1980 | 141 | 0.010 |
Why?
|
| Anti-Infective Agents | 1 | 2007 | 986 | 0.010 |
Why?
|
| Radiography | 1 | 2011 | 6975 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 2002 | 793 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2000 | 411 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 16036 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2004 | 1743 | 0.010 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2001 | 190 | 0.010 |
Why?
|
| Pulmonary Artery | 1 | 2009 | 1944 | 0.010 |
Why?
|
| Phantoms, Imaging | 1 | 2008 | 2487 | 0.010 |
Why?
|
| Penicillamine | 1 | 1999 | 60 | 0.010 |
Why?
|
| Troponin | 1 | 2003 | 536 | 0.010 |
Why?
|
| Heparitin Sulfate | 1 | 2001 | 223 | 0.010 |
Why?
|
| Endopeptidases | 1 | 2003 | 762 | 0.010 |
Why?
|
| Losartan | 1 | 2001 | 262 | 0.010 |
Why?
|
| Registries | 1 | 2016 | 8351 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1981 | 1309 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2008 | 2568 | 0.010 |
Why?
|
| Nasal Mucosa | 1 | 2002 | 416 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2006 | 2931 | 0.010 |
Why?
|
| Potassium | 2 | 1974 | 1314 | 0.010 |
Why?
|
| Leucine | 1 | 1980 | 547 | 0.010 |
Why?
|
| Ionomycin | 1 | 1998 | 109 | 0.010 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2004 | 788 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2003 | 1587 | 0.010 |
Why?
|
| Troponin I | 1 | 2003 | 659 | 0.010 |
Why?
|
| Oxidative Phosphorylation | 1 | 1981 | 501 | 0.010 |
Why?
|
| Ionophores | 1 | 1998 | 108 | 0.010 |
Why?
|
| Papillary Muscles | 1 | 1999 | 192 | 0.010 |
Why?
|
| Thrombolytic Therapy | 1 | 2007 | 2054 | 0.010 |
Why?
|
| Dinoprost | 1 | 1998 | 139 | 0.010 |
Why?
|
| Heart Diseases | 1 | 2011 | 2817 | 0.010 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 1998 | 66 | 0.010 |
Why?
|
| Alanine | 1 | 1980 | 613 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1970 | 2330 | 0.010 |
Why?
|
| Fetal Heart | 1 | 1979 | 281 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1998 | 425 | 0.010 |
Why?
|
| Antigens, Bacterial | 1 | 2002 | 1148 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 1998 | 313 | 0.010 |
Why?
|
| Lung | 1 | 2015 | 10076 | 0.010 |
Why?
|
| Chromatography, DEAE-Cellulose | 1 | 1976 | 81 | 0.010 |
Why?
|
| Hypothermia, Induced | 1 | 2002 | 754 | 0.010 |
Why?
|
| Systole | 1 | 1999 | 935 | 0.010 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1996 | 73 | 0.010 |
Why?
|
| Isoantibodies | 1 | 2000 | 681 | 0.010 |
Why?
|
| Antibodies, Bacterial | 1 | 2002 | 1477 | 0.010 |
Why?
|
| Caspase 3 | 1 | 1998 | 730 | 0.010 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1996 | 221 | 0.010 |
Why?
|
| Virulence | 1 | 2000 | 1294 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1998 | 1623 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 2003 | 1540 | 0.010 |
Why?
|
| Lymphocyte Depletion | 1 | 1998 | 605 | 0.010 |
Why?
|
| Elasticity | 1 | 1998 | 654 | 0.010 |
Why?
|
| Defective Viruses | 1 | 1995 | 89 | 0.010 |
Why?
|
| Complement Fixation Tests | 1 | 1975 | 67 | 0.010 |
Why?
|
| International Cooperation | 1 | 2002 | 1434 | 0.010 |
Why?
|
| Pulmonary Embolism | 1 | 2009 | 2598 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 1998 | 582 | 0.010 |
Why?
|
| Receptors, CXCR4 | 1 | 2000 | 729 | 0.010 |
Why?
|
| Skin Transplantation | 1 | 2000 | 1097 | 0.010 |
Why?
|
| Brachial Artery | 1 | 1996 | 373 | 0.010 |
Why?
|
| Binding Sites, Antibody | 1 | 1975 | 340 | 0.010 |
Why?
|
| Physical Examination | 1 | 1981 | 1265 | 0.010 |
Why?
|
| Anaerobiosis | 1 | 1974 | 140 | 0.010 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2001 | 1065 | 0.010 |
Why?
|
| Haplotypes | 1 | 2000 | 2722 | 0.010 |
Why?
|
| Atrophy | 1 | 1979 | 1631 | 0.010 |
Why?
|
| Myocardial Contraction | 1 | 1979 | 1516 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2000 | 1676 | 0.010 |
Why?
|
| Genome, Human | 1 | 2007 | 4441 | 0.010 |
Why?
|
| Desoxycorticosterone | 1 | 1973 | 46 | 0.010 |
Why?
|
| Fludrocortisone | 1 | 1973 | 24 | 0.010 |
Why?
|
| Estriol | 1 | 1972 | 53 | 0.010 |
Why?
|
| Diethylstilbestrol | 1 | 1972 | 85 | 0.010 |
Why?
|
| Indoles | 1 | 2001 | 1836 | 0.010 |
Why?
|
| Isoantigens | 1 | 1995 | 562 | 0.010 |
Why?
|
| Estrogen Antagonists | 1 | 1972 | 151 | 0.010 |
Why?
|
| Cytoplasm | 1 | 1997 | 1504 | 0.010 |
Why?
|
| Naphthalenes | 1 | 1972 | 198 | 0.010 |
Why?
|
| Acetanilides | 1 | 1973 | 168 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2002 | 3468 | 0.010 |
Why?
|
| Goals | 1 | 1996 | 717 | 0.010 |
Why?
|
| Emergency Medical Services | 1 | 2002 | 1936 | 0.010 |
Why?
|
| Sulfur Isotopes | 1 | 1969 | 21 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 1981 | 2780 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2003 | 8732 | 0.010 |
Why?
|
| Perfusion | 1 | 1974 | 1409 | 0.010 |
Why?
|
| 1-Phosphatidylinositol 4-Kinase | 1 | 1989 | 59 | 0.010 |
Why?
|
| Eflornithine | 1 | 1988 | 31 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 1995 | 1751 | 0.000 |
Why?
|
| Inositol Phosphates | 1 | 1989 | 175 | 0.000 |
Why?
|
| Progesterone | 1 | 1973 | 752 | 0.000 |
Why?
|
| Surgical Procedures, Operative | 1 | 1980 | 1931 | 0.000 |
Why?
|
| Filtration | 1 | 1989 | 227 | 0.000 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 1989 | 178 | 0.000 |
Why?
|
| Phenols | 1 | 1972 | 526 | 0.000 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 1989 | 201 | 0.000 |
Why?
|
| Arterial Occlusive Diseases | 1 | 1972 | 743 | 0.000 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 1988 | 317 | 0.000 |
Why?
|
| Phosphotyrosine | 1 | 1989 | 458 | 0.000 |
Why?
|
| Phosphotransferases | 1 | 1989 | 302 | 0.000 |
Why?
|
| Microsomes | 1 | 1968 | 252 | 0.000 |
Why?
|
| Cell-Free System | 1 | 1968 | 339 | 0.000 |
Why?
|
| Carbon Isotopes | 1 | 1968 | 453 | 0.000 |
Why?
|
| Retroviridae | 1 | 1989 | 846 | 0.000 |
Why?
|
| Shock, Cardiogenic | 1 | 1972 | 709 | 0.000 |
Why?
|
| Genes, ras | 1 | 1988 | 656 | 0.000 |
Why?
|
| Receptors, Fc | 1 | 1989 | 537 | 0.000 |
Why?
|
| Young Adult | 1 | 2012 | 59980 | 0.000 |
Why?
|
| Culture Media | 1 | 1987 | 892 | 0.000 |
Why?
|
| Tyrosine | 1 | 1989 | 1425 | 0.000 |
Why?
|
| HLA-DR Antigens | 1 | 1986 | 609 | 0.000 |
Why?
|
| Liver Neoplasms | 2 | 1970 | 4357 | 0.000 |
Why?
|
| Mitosis | 1 | 1989 | 1176 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 1969 | 21178 | 0.000 |
Why?
|
| Chromatin | 1 | 1972 | 2980 | 0.000 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 1986 | 976 | 0.000 |
Why?
|
| Neoplasm Metastasis | 1 | 1969 | 4892 | 0.000 |
Why?
|
| Injections, Intradermal | 1 | 1977 | 116 | 0.000 |
Why?
|
| Mitochondria | 1 | 1968 | 3678 | 0.000 |
Why?
|
| Spectrophotometry | 1 | 1972 | 291 | 0.000 |
Why?
|
| Infusions, Parenteral | 1 | 1972 | 395 | 0.000 |
Why?
|
| Skin | 1 | 1986 | 4499 | 0.000 |
Why?
|
| Glycogen | 1 | 1972 | 252 | 0.000 |
Why?
|
| Methods | 1 | 1972 | 1065 | 0.000 |
Why?
|
| Electrodes | 1 | 1972 | 612 | 0.000 |
Why?
|
| Drug Combinations | 1 | 1972 | 2086 | 0.000 |
Why?
|
| Hypotension | 1 | 1972 | 888 | 0.000 |
Why?
|